Myeloid cell-specific ablation of the mineralocorticoid receptor attenuates experimental autoimmune encephalomyelitis by Li, Xiao
Myeloid cell-specific ablation of the mineralocorticoid 














    for the award of the degree “Doctor rerum naturalium (Dr. rer. Nat.)” 
    Division of Mathematics and Natural Sciences of the 



















Prof. Dr. Holger M. Reichardt 
 
Doctoral Committee: 
Prof. Dr. Holger M. Reichardt                              (1st Referee) 
         Cellular and molecular Immunology 
         University of Göttingen Medical School 
 
 
Prof. Dr. Lutz Walter                                     (2nd Referee) 
         Abteilung Primatengenetik 
         Deutsches Primatenzentrum 
 
 
Prof. Dr. Steven A. Johnsen 
         Molecular Oncology 

















        I hereby declare that I have written this PhD thesis entitled “Myeloid 
cell-specific ablation of the mineralocorticoid receptor attenuates experimental 
autoimmune encephalomyelitis” independently and with no other sources and 








List of abbreviations 
 
APC Antigen presenting cell BMDM 
Bone marrow derived 
macrophage 









FBS Fetal bovine serum 
GC Glucocorticoid siRNA Small interference RNA 
GR Glucocorticoid receptor RNA Ribonucleic acid 










NO Nitric oxide PMA 
Phorbol 12-myristate 
13-acetate 












Prefixes & Units 
 
k kilo l liter 
c centi M molar 
m milli g gram 
µ micro bp base-pair 
n nano Da dalton 
p pico s second 
U unit g 
acceleration of gravity 
cm centi meter V volt 
h hour min minute 





The mineralocorticoid receptor (MR) plays an essential role in regulating fluid 
and electrolyte homeostasis. Amongst hematopoietic cells, also macrophages 
express the MR but, unlike kidney or colon, they do not co-express the enzyme 
11β-hydroxysteroid dehydrogenase type II (11β-HSDII). Consequently, 
glucocorticoids (GC) in macrophages are able not only to activate the GC 
receptor (GR) but also the MR, and the balance between both effects 
determines macrophage fate. It had been hypothesized that the absence of the 
MR induces polarization towards alternatively activated macrophages (AAM), 
which are known to have anti-inflammatory and wound-healing features. The 
aim of this study was to obtain further insight into the role of the MR in 
macrophage polarization and its effects on neuroinflammation in vivo. 
This work shows that MR knockout macrophages are skewed towards an AAM 
phenotype. However, these AAMs have different characteristics compared to 
those induced by IL-4 and IL-13. In vitro, MR knockout macrophages are 
characterized by reduced iNOS and increase in Arginase1 expression. This is 
supported by in vivo results obtained by inducing experimental autoimmune 
encephalomyelitis (EAE) mimicking multiple sclerosis (MS) in MRlysMcre and 
MRflox/flox mice. In this disease model, the mutant mice suffer significantly less 
from EAE than control mice. Macrophages both from the spinal cord and the 
peritoneal cavity of diseased MRlysMcre mice show a polarization towards the 
AAM phenotype. Histological analysis of MRlysMcre mice suffering from EAE 
confirmed that the pathophysiological features were less severe compared to 
control mice. Thus, ablation of the MR in macrophages induces their 
polarization towards AAM thereby ameliorating EAE.  
Since MR disruption from early development on may induce compensatory 
mechanisms, new transgenic mice should be developed allowing for an 
inducible and reversible deletion of the MR in the hematopoietic system. To 
this end lentiviral vectors for the inactivation of the MR by RNA interference 
were successfully developed and tested. They were produced at high titers, 
injected into fertilized mouse oocytes and transgenic offspring was identified 
that had integrated the new vector. In the future, this new model should 
become instrumental in analyzing the role of the MR in the control of the 
immune system.  
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1.1 Mineralocorticoid receptor (MR) 
 
1.1.1  Steroid hormone-receptor superfamily 
 
Steroid hormone receptors (SHRs) compose a subgroup of nuclear 
receptor (NC) superfamily. SHRs are involved in diverse physiological 
processes in animals, such as homeostasis, reproduction, development 
and metabolism, through binding with their ligands including: cortisol, 
aldosterone, progesterone, and Estrogen.  
The SHRs are characterized by a unique modular structure model: It 
contains a variable N-terminal region, a DNA binding domain (DBD), which 
is comprised of two zinc-finger motifs and responsible for DNA-protein or 
protein-protein interaction, the ligand-binding domain (LBD) located at the 
C-terminal region, which, is moderately conserved and folds into a 
canonical α-helical sandwich generally consisting of 12 α-helices (H1 to 
H12) (Lewis et al., 2005). 
MR is the unique receptor among these receptors having two classes of 
hormone of ligands, the mineralocorticoids (MCs), aldosterone, and the 
glucocorticoids (GCs), cortisol (in human) and corticosterone (in rodent) 
(Mangelsdorf et al., 1995). This physiological character is the 
consequence of the highly homologous sequence between MR and 
glucocorticoid receptor (GR). The human GR and MR are ~56% identical 
in the steroid-binding domain (Pippal and Fuller 2008). Furthermore, 
ligand-binding studies of MR indicated that cortisol and aldosterone have a 






1.1.2  Transcriptional Mechanisms 
 
Initiation of SHR activity requires the binding of a specific ligand, such as 
GCs in the case of the GR. The SHRs then dimerize and translocate to the 
nucleus, and bind to their appropriate hormone response element (HRE) in 
the promoter of their target genes. Consequently, the SHRs recruit 
transcriptional co-regulatory proteins and ultimately RNA polymerase II 
and other components of the transcriptional machinery, commencing the 
transcription process (Horisberger et al., 1991). 
 
1.1.3  Molecular features of MR  
 
The mouse MR gene has been mapped to chromosome 8 and spans over 
341 kb and is composed of 9 exons encoding the fulllength 980 amino acid 
MR protein. Similar to the other members of the nuclear receptor 
superfamily MR includes four structurally distinct domains: the N-terminal 
domain (NTD), which contains activation function-1 (AF-1) and mediates 
ligand-independent interactions of the receptor with other nuclear proteins 
that initiate target gene transcription, followed by a central DNA-binding 
domain (DBD), which contains two zinc fingers that interact with specific 
hormone response elements (HRE) in the promoter regions of MR target 
genes, the hinge region and the C-terminal ligand-binding domain (LBD), 
which responses to binding ligand and contains a ligand-dependent 
activation function-2 (AF-2) (Pascual-Le et al., 2005; Govindan and 
Warriar, 1998). 
The NTD has a highly conserved amino acid sequence, ~85% 
homologous, in all MRs of mammals (Luisi et al., 1991). The AF-1 in the 
NTD is important for interactions with the transcriptional coregulators and 
for intramolecular interactions with the LBD (Bledsoe et al., 2005). The 





binding. The DBD shares a highly conserved amino acid sequence with 
the other members of the steroid receptor superfamily, particularly with that 
of GR, ~94% identity. Hence GR and MR share the same hormone 
response elements, GRE and MRE (Mangelsdorf et al., 1995). Additionally, 
the DBD is also response for homo- and heterodimerization (Li et al., 
2005). The LBD transforms upon binding ligand and represents the AF-2 
that interacts with coactivators containing an LxxLL motif (Stewart and 
Mason et al., 1995; Perissi et al., 2005).Though the MR LBD has ~55% 
homology with that of GR, they share considerable structural and 
functional homology. Nonetheless, only the GCs bind to the MR with a 
similar affinity with aldosterone, but the aldosterone binds to the GR 
requiring a high, non-physiological concentration. In tissues the ligand 
specifity is ensured by expressing enzyme 11β-hydroxysteroid 
dehydrogenase type 2 (11βHSD2), which metabolizes cortisol or 
corticosterone into inactive metabolites, cortisone, that are unable to bind 
MR (Canessa et al., 1994). 
 
1.1.4  Physiological functions of MR and its role in the immune 
system 
 
The first known function of MR is regulating fluid and electrolytes 
homeostasis in epithelial tissues, such as kidney, colon etc., through direct 
stimulation the expression of specific ionic transporters, such as the 
amiloride-sensitive epithelial Na channel (ENaC), and the basolateral Na+, 
K+-ATPase pump (Viengchareun et al., 2007; Hsueh et al., 1998). These 
transporters are located in the apical membrane and responsible for 
unidirectional transepithelial sodium transport from the lumen to the 
basolateral space (Pu et al., 2003). 
Moreover, new experimental and clinical data indicate that aldosterone can 





vasculature (Brown, 2008; Moraes et al., 2005). The in vivo and in vitro 
studies showed that the MR activation induces oxidative stress, vascular 
inflammation, and an increase in the expression of inflammatory 
biomarkers, such as fibrinogen and plasminogen activator inhibitor-1, 
which may contributes to progressive renal dysfunction and congestive 
heart failure (Lijnen et al., 1999; Schmidt et al., 2006; Leibovitz et al., 2009; 
Nishimura et al., 2008). In these aldosterone-induced inflammation 
diseases the macrophages attracted attention as a critical role. Leibovitz et 
al. has first reported the monocyte/macrophage is involved in 
aldosterone-induced oxidative stress and endothelial dysfunction 
(Fraccarollo et al., 2008). Many studies showed that administration of MR 
antagonists, spironolactone or eplerenone, reduces macrophage 
accumulation in many inflammatory diseases, such as peritoneal fibrosis 
(Rocha et al., 2002), myocardial infarction (Young et al., 2003) and 
angiotensin II-and aldosterone-induced vascular inflammation and 
damage (Calò et al., 2004; Herrada et al., 2010), whereas in macrophages, 
aldosterone treatment enhances expression of the inflammatory and 
oxidative stress markers (Ward et al., 1951). Gathering these date suggest 
a role of specific macrophages MR signaling in mediation the 
pro-inflammatory and oxidative phenotype in many pathologies. 
Additionally, MR can also alter the functions of dendritic cells (DCs), 
another cell type acts as antigen-presenting cells (APCs) by activating T 
cells to evoke the adaptive immunity (Hench et al., 1949). 
 
1.1.5  Physiological functions of GR and its role in the immune system 
 
GR is a steroid receptor, belongs to the NR family of ligand-dependent 
transcription factor. GR’s specific ligand (Caelles et al., 1997), GC is a term 
for all cholesterol-derived steroid molecules, which are important for 





Kendall, Tadeus Reichstein, and Philip Hench were awarded the Nobel 
Prize in 1950 for their work on isolating, synthesizing, and delivering 
cortisol (Miesfeld et al., 1984; Auphan et al., 1995), which leads to the 
discovery of cortisone as a therapeutic agent for rheumatoid arthritis. 
Since then GC and its synthetic derivates are in widespread use to treat 
inflammatory diseases, such as asthma, multiple sclerosis and allergy, etc. 
GR simultaneously affects the activation and effecter functions of immune 
cells, from both innate and adaptive immune systems, through 
manipulation of their transcriptional pathways. GR exerts anti-inflammatory 
effects through two mechanisms: DNA-binding-independent 
transrepression and DNA-binding- dependent transactivation. 
Transrepression does not require either GR dimerazation or binding to 
DNA (Reichardt et al., 2001), but by direct interaction of GR monomer with 
inflammatory transcription pathways, including AP-1 (Lim et al., 2007), 
NF-κB (Wang et al., 2006) signaling. Transactivation can induce 
transcription of anti-inflammatory genes, including IL10, GILZ, MKP-1 and 
IκBα (Reichardt et al., 1998, Tuckermann et al., 1999), which blockade the 
inflammatory transcription pathways by targeting signaling molecules in 
those pathways. Sight on the cellular response, GR can reduce 
macrophage-induced inflammatory responses (Ramírez et al., 1996), such 
as NO- and TNFα-production, and induce T cell apoptosis (Avital et al., 
2006) or alter the T cell polarization (Datson et al., 2001). 
However, as introduced above, GC can act either through GR or MR, 
which may lead to different physiological consequences. So far, all the 
studies, which indicated the anti-inflammatory effect of GC, are based on 
the GR signaling. The ligand binding-affinity studies on macrophages raise 








1.1.6  Regulation of steroid hormone-receptors by Sirt1 
 
As introduced above, steroid hormone receptors play essential roles in 
numerous biological processes, such as homeostasis, metabolism, cell 
growth, and immune responses. Dysregulation of SHR signaling can lead 
to several types of tumors, such as breast cancer, leukemia and lymphoma, 
ovarian cancer, and lung cancer (Yang, 2006).  
Sirt1 is a NAD/NADH-dependent histone deacetylase (HDAC) that 
functions by deacetylating histone (H1, H3, and H4) and nonhistone 
proteins and involved in longevity, gene silencing, cell-cycle progression 
and energy homeostasis (Yamamoto, 2006; Dali-Youcef, 2007; Greiss and 
Gartner, 2009; Popov et al., 2007; Dai et al., 2007). Sirt1 has been 
reported involved in regulation of gene expression controlled by SHRs, 
such as androgen receptor (AR) (Yao et al., 2010; Lin et al., 2010), 
estrogen recetor (ER) (Yuan et al., 2009; Aoyagi and Archer, 2008), 
progesterone receptor (PR) (Amat et al., 2007; Zhang et al., 2009), GR 
and MR (Brand and Esteves, 2005; Fan et al., 2011). Here we particularly 
focus on the interactions between Sirt1, GR and MR. 
The recent studies of the interaction between GR and Sirt1 are restricted 
in mitochondria related regulation of metabolism in skeletal muscle cells. 
After binding with ligand GR activates the transcription of uncoupling 
protein-3 (UCP3), a mitochondrial membrane transporter that protects 
muscle cells from an overload of fatty acids and protects against excessive 
production of reactive oxygen species (Schenk et al., 2011). This process 
requires interaction between GR and the co-activator p300 at the promoter, 
which is possibly completely inhibited by Sirt1 or its activator resveratrol 
(Brand and Esteves, 2005). Despite it has been long reported p300 as well 
as GR play important role in inflammatory or auto-immune diseases, so far 






In the case of MR, so far the interaction between Sirt1 and MR remains 
also widely unclear. Only a few papers (Fan et al., 2011, Rutschman et al., 
2001) showed: on the one hand Sirt1 can suppress the MR mediated gene 
transcription, such as αENaC, without its deacetylase activity; on the other 
hand Sirt1 expression is also under the control of aldosterone. 
Although there is no evidence linking the interaction of GR/MR and Sirt1 
with immune diseases, it is been known that Sirt1 regulates PI3K, an 
important component of many of the steroid hormone signaing pathways, 
depending on cellular metabolism level (Schebesch et al., 1997), which 
provides us a clue to find the involvement of Sirt1 in immune system 




Macrophages play important role in innate as well adaptive immunity, by 
phagocyting pathogens and as antigen presenting cell (APC) stimulating 
lymphocytes to respond to pathogens, respectively. 
The macrophages are generated from committed hematopoietic stem cells 
located in the bone marrow. Macrophage precursors leave bone marrow 
as monocytes and circulate throughout the body until they are recruited in 
tissues, including the spleen, which serves as a storage reservoir for 
immature monocytes (Gordon, 2003). After drilling into tissues the 
monocytes become specialized tissue-resident macrophages including 
osteoclasts (bone), alveolar macrophages (lung), Kupffer cells (liver) and 
microglia cells (central nervous system (CNS)). 
Depending on the specific milieu, such as altered host cells, modified 
molecules and exogenous agents, the macrophages can be activated 
generally into two types, classically activated macrophages (CAM) and 





distinct functions not only in immunity but also in many other physiological 
processes. 
 
1.2.1  Classically activated macrophages (CAM) 
 
The “classical” activation of macrophages was first studied in the 1960s by 
Mackaness and colleagues (Goverman, 2011) by showing that infection of 
mice with Mycobacterium bovis bacillus Calmette-Guerin (BCG) or Listeria 
monocytogenes enhanced the antimicrobial activities of macrophages in a 
stimulus dependent, but unspecific, manner (Dull, 1998). The polarization 
of macrophages toward the CAM phenotype is promoted by bacterial 
moieties such as lipopolysaccharide (LPS) and the TH1 cytokine 
interferon-γ (IFN-γ) (Dull, 1998). These CAM exhibit a TH1 related 
inflammatory response, such as producing large amounts of 
proinflammatory cytokines and generate reactive oxygen (ROI) and nitric 
oxide through the inducible nitric oxide synthase (iNOS or NOS2). The 
response of CAM contributes to cellular immunity, immunodeficiency 
syndromes and tissue damage. 
 
1.2.2  Alternatively activated macrophages (AAM) 
 
AAM, also termed as M2 macrophages, were typically defined by 
alternative activation by IL-4 and IL-13, typical TH2 cytokines. Thereafter, it 
is been found the macrophages, which are activated by transforming 
growth factor (TGF) family of cytokines, glucocorticoids, macrophage 
colony-stimulating factor (M-CSF), overlaps patterns of gene expression 
with the AAMs, which are activated by IL-4 and IL-13 (Arriza et al., 1987). 
AAMs have potential to mediate wound-healing, angiogenesis, 
anti-inflammatory response. 





example, CD163, mannose receptor (CD206), scavenger receptor2 (Msr2), 
F13a1, Fizz1, Ym1, Arginase1 and MHC II molecules (Gordon, 2003). Due 
to induction of Arginase, AAMs do not produce NO in contrast to CAMs 
(Mosser, 2003).  
 
1.2.3  Effects of sterocorticoids on the differentiation of 
macrophages 
 
Corticosteroids include two classes of steroid hormones, GC and MC. It 
has long been known that in absence of 11βHSD2 MR coordinate the 
cellular responses against that of GR in brain (Richard and Young, 2009; 
Richard et al., 2009). These two corticosteroid receptors spread their 
counteractions on macrophage responses (Tanaka et al., 1997; Usher et 
al., 2010; Hench et al., 1950), and further on macrophage polarization 
(Gratchey et al., 2005).  
The GC induced AAM shares with that induced by IL-4 some common 
characteristics, such as repression the inflammatory cytokines by inhibition 
of NFκB and AP-1, increase in expression of the macrophage mannose 
receptor and elevation of endocytosis. Nonetheless, due to different 
signaling pathways, GR counteracts against IL-4, particularly on 
expression of extracellular matrix (ECM) proteins (Iglarz et al., 2003). 
In absence of 11βHSD2, macrophage MR is overwhelmingly occupied by 
GC. Furthermore, MR and GR have largely opposing roles in 
macrophages, and the effects of MR are independent of GR (Lyons et al., 
2007). The putative effect of MR on macrophages polarization was elicited 
by the studies on Peroxisome Proliferator-Activated Receptor 
gamma (PPARγ), a nuclear hormone receptor. The activated PPARγ can 
also polarize macrophages towards alternatively activated state and 
partially overlaps that activated by GR (Caglayan et al., 2008). On the 





inflammation and fibrosis was found to be similar to that of activation of 
PPARγ by pioglitazone (Usher et al., 2010; Blasi et al., 2003). As Usher 
and his colleagues, 2010 showed: MR inhibition eliminates a suppression 
of AAM polarization, resulting in a macrophage phenotype that is similar to 
that induced by GCs (acting through GR). 
Gathering the information together, the GR and MR play opposing roles in 
macrophages and skew macrophage polarization toward AAM and CAM, 
respectively.   
 
1.2.4  Role of Macrophages in neuroinflammatory diseases  
 
Neuroinflammation represents a coordinated cellular response to tissue 
damage, including diseases such as MS, Alzheimer’s disease (AD) and 
Parkinson’s disease (PD). Hence, the inflammatory responses on tissue 
injury induced by the CNS resident macrophages, microglias, and 
infiltrating macrophages in case of MS attract many focuses. 
Microglias in the CNS serve as the resident immune cells and provide the 
first line of defense against invading microbes. In healthy individual, the 
neurons express CD200 (Kraft and Harry, 2011) to maintain the microglias 
in a quiescent state through the CD200 receptor (CD200R) on microglias 
surface (Colton, 1995). Under stress or damages the neurons release 
specific factors, such as matrix metalloproteinase-3 (MMP-3), 
neuromelanin, heat shock proteins (HSP60, HSP70, HSP90), DNA, 
proteases, uric acid and the chromosomal protein high-mobility group B1 
(HMGB1) (Thiel and Audus, 2001). These stimulate inflammatory 
response through NFκB and AP-1 signaling pathways, which modulate 
pro-inflammatory target genes encoding cytokines, chemokines, enzymes, 
and other molecules essential for pathogen elimination. Additionally, 
microglia express iNOS, which uses L-arginine to produce NO, which is 





oligodendrocytes in culture and studies of direct effects on BBB 
permeability (Bal-Price et al., 2001; Brodie et al., 1998), which may 
contributes to infiltration of the leukocytes from blood into CNS. NO can 
also inhibit neuronal respiration, causing depolarization, glutamate release 
from neurons and astrocytes (Kitamura et al. 2000; Odegaard et al., 2007).  
Since the inflammatory responses induced by macrophages play a pivotal 
role in neuron degeneration, induction of the AAM in the microglia and 
infiltrating macrophage population becomes a potential approach to 
reduce neuroinflammatory diseases severity. First, the polarization 
skewing from CAM to AAM switches the macrophages from a 
proinflammatory to an anti-inflammatory state, in which the expression 
levels of proinflammatory cytokines are reduced, such as IL1β, IL6 and 
TNFα etc, and the expression of IL10, TGF-β, insulin growth factor 1 
(IGF-1) and PPARγ are elevated, which are generally associated with the 
repair and reconstruction after injury (van Rossum et al., 2008; Siffrin et al., 
2007; Beeton et al., 2007; Schreiner et al., 2009). Second, the AAMs 
express more Arginase1 and less iNOS, which results in reduced NO 
levels in CNS. Third, the AAMs exert a higher phagocytotic activity of 
apoptotic cells compared to CAMs, which may facilitate the clearance of 
the lesion sites in CNS and neuron regeneration. 
 
1.3 Multiple sclerosis (MS) and Experimental autoimmune 
encephalomyelitis (EAE) 
 
MS, a chronic neuroinflammatory demyelinating disease was initially 
identified in 1868 by Charcot. This disease often begins in young 
adulthood with intermittent episodes of neurological dysfunction, including 
visual impairment, ataxia, motor and sensory deficits, and bowel and 





attacks on the white matter of the brain and spinal cord, which lead to the 
accumulation of perivascularly distributed inflammatory cells within the 
brain and spinal cord white matter (Rivers et al., 1933). 
Beeton et al. first established an animal model of MS in the 1930s, when 
they immunized monkeys with a central nervous system (CNS) 
homogenate to induce what is now known as experimental autoimmune 
encephalomyelitis (EAE) (Steinman et al., 2006). Since then EAE has 
become the most accepted animal model of MS. In recent decades, 
pathogenic hypotheses have been investigated and novel therapeutic 
agents tested in this model in the fields of CNS inflammation and 
demyelination. Therefore, EAE provides a valuable tool for the 
investigation of the T-cell-dependent pathogenesis of autoimmune 
inflammation in the CNS and the orchestration of the autoimmune 
demyelinating inflammation in the CNS of MS patients. Mice and/or 
genetically modified mice have also been of fundamental value in the 
exploration of the complex pathogenesis of MS (Chiu et al., 2009; Nielsen 
et al., 2006). EAE is undoubtedly the best animal model in which to study 
autoimmune diseases and particularly the demyelinating diseases of the 
CNS, such as MS (Berger et al., 2005). 
 
1.4 RNA interference 
 
A key aspect of the regulation of eukaryotic gene expression is the 
cytoplasmic control of mRNA translation and degeneration. Over the last 
decade, miRNAs and siRNAs have raised as novel important regulators of 
translation and mRNA degradation. The relative regulations mediated by 
these small RNAs are referred to as RNA interference (RNAi) or RNA 
silencing. There are two general pathways to silence cytoplasmic mRNAs 





repression, or by enhancing mRNA degradation (Carmell and Hannon, 
2004). Previously, it has been thought that the difference between these 
two silencers was the different outcomes of silencing, miRNA repressed 
the translation and siRNA enhanced degradation of mRNA. However, the 
recent findings showed both miRNA and siRNA are functionally equivalent, 
and their outcome of silencing depends on the extent of base pairing 
(Zeng et al., 2003; Denli et al., 2004), enhancing mRNA degradation by 
complete complementary in sequence or repressing translation by partial 
complementarity. Nonetheless, they can still be distinguished by their 
mode of biogenesis (Hutvagner and Zamore, 2002; Doench et al., 2003): 
miRNAs are produced endogenously from transcripts that form stem-loop 
structures, while siRNA are produced artificial or also endogenously 
processed from long double-stranded RNA (dsRNA) and complex hairpin 
precursors (shRNA) by sharing the same producing machinery with 
miRNA. 
Since I used lentivirus to transfect target cells with plasmid encoding the 
sequence, which formed shRNA structure after transcription, I will only use 
the term siRNA in following text.  
 
1.4.1  The Mechanisms of RNA interference 
 
The first precursor of shRNA, is a transcript in the nucleus made by 
polymerase II or polymerase III and forms a stem-loop structure. This 
transcription product is processed in the nucleus by a complex comprised 
of at least two components: the RNase III enzyme Drosha, and a protein 
DGCR8 (homologue protein in yeast called Pasha) (Gregory et al., 2004; 
Han et al., 2004; Landthaler et al., 2004; Lee et al., 2003; Yi et al., 2003; 
Lund et al., 2004). The intermediate, termed pre-shRNA due to its “hair 
spin” similar structure is then exported from nucleus in cytoplasm by 





RNA (dsRNA) by the cytoplasmic RNase III endonuclease Dicer complex 
(Gregory et al., 2005; Glaser et al., 2005). Final processing by Dicer 
coupled to assembly of the dsRNA intermediate into RNA-induced 
silencing complex (RISC) (Benson et al., 2006), where the sense 
(passenger) strand is degraded. The left antisense (guide) strand leads 
RISC to mRNA that has a complementary sequence. As above mentioned, 
the degree of complementarity determines the mRNA degradation or 
disruption of translation.   
 
1.4.2  The Inducible and reversible gene knockdown system 
 
The development of knockout mice by homologous recombination in 
embryonic stem cells (Seibler et al., 2007) is a revolutionary method for 
research in many fields in medicine and biology. Nevertheless, this method 
cannot fulfill every requirement in research, due to its limitation: It is not 
suitable for all genes that are indispensable for individual development and 
not reversible. The novel shRNA technique provides an efficient approach 
for this goal by using engineered RNA polymerase III-dependent 
promoters containing operator sequence (tetO) of the tetracycline 
resistance operon (Szymczak and Vignali, 2005; Geissmann et al., 2010 
and Figure 1).                     
                





Herold et al., 2008. The vector contains two cassettes: the shRNA is placed in the first 
one and regulated by the H1 promoter with tetO; the tetR and EGFP are linked by viral 
T2A peptide and constitutively expressed unter ubiquitin C promoter (Ub-p). In the 
absence of Dox, the tetR binds to tetO and blocks shRNA transcription. After addition of 
Dox, the tetR is removed, which allows the shRNA transcription occurring.  
        
This novel gene knockdown system is comprised of two cassettes. The 
first and second cassettes both have its own promoter, H1-promoter (H1-p) 
and ubiquitin C promoter (Ub-p), respectively. The shRNA sequence is 
placed in the first cassette downstream of the H1-p, which is controlled by 
the tetO. In the second cassette, the Ub-p is responsible for the expression 
of the downstream tet represser (tetR) and eGFP. Independent expression 
of these two genes under one promoter was guaranteed by the viral T2A 
peptide (Machaness, 1964), which is placed between the tetR and eGFP. 
tetR is continuously expressed and binds immediately to tetO, which leads 
to inhibiton of shRNA transcription. Addition of doxycycline rescues H1-p 
activity by removing tetR from tetO, which allows the transcription of 
shRNA occurring.  
With this engineered system, shRNA transcription can be controlled by this 
operon, so that we can temporally and reversibly knockdown the target 
gene expression by “turning on” or “turning off” the operon. Hence this 
technique can help us avoid such problems by generating transgenic mice, 
in which the target protein is essential for individual development and 
growth. 
 
1.4.3  Lentiviruses and their use as vector systems 
 
Derived from HIV, Lentivirus, a genus of the retroviridae family, becomes a                     
powerful vehicle for gene delivery in vivo, because of their unique ability to 





(Yee et al., 1994). Since the first application of lentivirus in research, their 
biosafety is of major concern.  
The complexity of the lentivirus genome provides a chance to archive 
biosafety in practical application. In addition to the structural gag, pol, and 
env genes shared with all retroviruses, HIV contains two regulatory genes, 
tat and rev, essential for viral replication, and four accessory genes, vif, vpr, 
vpu, and nef, which are not crucial for viral growth but are critical for in vivo 
pathogenesis (Moore et al., 2012). In order to archive biosafety in 
application, we used a four-plasmid vector system, termed the third 
generation lentiviral vector system. In this system the target gene is placed 
in one plasmid and the other essential genes are separated in three 
plasmids: gag and pol, coding for the virion main structural proteins and 
the retrovirus-specific enzymes, respectively, are driven by CMV promoter 
and placed in pMDLg/pRRE; The Rev response element (RRE) is 
immediately placed downstream of gag and pol sequence; RRE binding 
with Rev, whose cDNA is encoded by rev separately placed in pRSV-Rev, 
facilitates exporting mRNA of gag and pol genes from nucleus; the env is 
replaced by vsv-g, coding the G glycoprotein of the vesicular stomatitis 
virus, is also alone placed on a third helper plasmid and under the control 
of the CMV promoter (Haigis et al., 2006); the VSV-G enhances the 
tropism of virus and facilitates infection. Due to demand of biosafety, after 
delivery of gene into target cells by lentiviruses we do not need any 
replication competent lentivirus (RCL) to be generated in target cells. In 
the three helper plasmids, the packaging sequence (Psi) is deleted, which 
prevents the transcript mRNAs of these structural proteins assembled into 
the new generated viral particle. Only one the plasmid with the gene of 
interest is transcript with Psi and gets incorporated into the new viruses. 
Hence, the new generated viruses can only infect the target cells but are 
not able to reproduce themselves. There is only one possibility that they 





recombination the Psi is also placed in the all three helper plasmids. 
Therefore, by splitting the vector system into four plasmids (3 helper and 1 
vector), the number of recombination events required to form a complete 
RCL increases enormously. To date there are no known cases where this 




The aim of this project was to determine the role of MR in macrophage 
polarization. If our hypothesis that MR knockout can skew macrophage 
polarization more towards AAM, the individual could benefit from the AAM 
polarization in inflammatory diseases, such as the EAE model. It can also 
expend our knowledge about the metabolism and immune system, as well 
as provide new approach to reduce disease severity. 
Furthermore if during this project, the generation of new transgenic mice is 
archived, the further study of the linkage between MR and immune system 










2.1 General equipments 
 
Accu-jet® pro pipette controlle Brand GmbH, Wertheim 
Arium® 611 laboratory water 
purification system 
Sartorius AG, Göttingen 
Centrifuge 5471R for reaction tubes Eppendorf, Hamburg 
Centrifuge 5904 for FACS tubes Eppendorf, Hamburg 
Centrifuge multifuge 4 KR for falcon 
tubes 
Heraeus, Hanau 
Centrifuge Sigma 2-5 for 96-well 
plates 
SIGMA Laborzentrifugen GmbH, 
Osterode am Harz 
Electrophoresis power supply 301 Amersham Biosciences, Freiburg 
Freezer Hera freeze -80°C Heraeus, Hanau 
Freezer Liebherr Comfort -20°C Liebherr-International Deutschland 
GmbH, Biberach an der Riss 
Freezer VIP plus -150°C SANYO Electric Co., Ltd., 
Moriguchi, Osaka, Japan 
Incubator, HERAcell 240 Heraeus, Hanau 
Laminar airflow cabinet, HERASafe Heraeus, Hanau 
Micropipettes 2.5 µl, 20 µl, 200 µl, 
1000 µl 
Eppendorf, Hamburg 
Microscope Primo Star Zeiss, Jena 





pH-Meter 766 Calimatic Knick Elektronische Messgeräte    
GmbH & Co. KG, Berlin 
RS 225 X-Ray Research System Gulmay Medical Systems, 
Camberley, Surrey, UK 
Scales TE313S Sartorius AG, Göttingen 
Shaker 3006 Gesellschaft für Labortechnik, 
Burgwedel 
UV System with camera and gel 
imager 
INTAS Science Imaging Instruments 
GmbH, Göttingen 
Vortex Genie-2 Scientific Industries,                    
Bohemia, New York, USA 










96-well Suspension Culture Plate, 
flat bottom 
Greiner bio-one GmbH, 
Frickenhausen 
Cell culture plates 3.5 cm, 6 cm, 10 
cm 
Sarstedt, Nümbrecht 
Cell strainer 40 µm BD biosciences, Heidelberg 
Cellstar® pipettes 5 ml, 10 ml, 25 ml Greiner bio-one GmbH, 
Frickenhausen 
CryoTubeTM Vials Nunc, Roskilde, Denmark 
ELISA plates Nunc, Roskilde, Denmark 
FACS tubes BD biosciences, Heidelberg 
Filtropur S 0.45 Sarstedt, Nümbrecht 
Needles B. Braun Melsungen AG, 
Melsungen 
Pipette tips 10 µl Sarstedt, Nümbrecht 
Pipette tips 200 µl, 1000 µl Greiner bio-one GmbH, 
Frickenhausen 
Reaction tube 1.5 ml, 2 ml Greiner bio-one GmbH, 
Frickenhausen 
Syringers 1 ml Henke Sass Wolf, Tuttlingen 
Syringers 2 ml, 5 ml, 10 ml BD biosciences, Heidelberg 
 
2.3 Chemicals and buffers 
 





Agarose UltraPure Invitrogen, Paisley, UK 
Bovine serum albumin (BSA) Carl Roth, Karlsruhe 
CaCl2·2H2O Merck, Darmstadt 
Citric acid Merck, Darmstadt 
Dex water soluble SIGMA-Aldrich, Taufkirchen 
Dimethyl sulfoxide (DMSO) Carl Roth, Karlsruhe 




Ethanol Carl Roth, Karlsruhe 
Ethidium bromide Carl Roth, Karlsruhe 
Fetal calf serum (FCS) HyClon, Peribio Science, Bonn 
GIBCO® Penicillin/Streptomycin Invitrogen, Paisley, UK 
H2O2 30% Carl Roth, Karlsruhe 
H2SO4 Merck, Darmstadt 
HCl Carl Roth, Karlsruhe 
4-(2-hydroxyethyl)-1-piperazineetha
ne-sulfonic acid (HEPES) 
Merck, Darmstadt 
KCl Merck, Darmstadt 
KH2PO4 Merck, Darmstadt 
KHCO3 Merck, Darmstadt 
Na2CO3 Merck, Darmstadt 
Na2HPO4·12 H2O Merck, Darmstadt 
Na3C6H5O7 Carl Roth, Karlsruhe 
NaCl Carl Roth, Karlsruhe 
NaH2PO4·H2O Merck, Darmstadt 
NaHCO3·3 H2O Merck, Darmstadt 
NaN3 Carl Roth, Karlsruhe 





Doxycycline SIGMA-Aldrich, Taufkirchen 
NH4Cl Merck, Darmstadt 
Percoll SIGMA-Aldrich, Taufkirchen 
Tris(hydroxymethyl)aminomethane 
(Tris) 
Carl Roth, Karlsruhe 
Tween-20 Carl Roth, Karlsruhe 
 
2.4 Media and solutions 
 
GIBCO® DMEM+GlutaMAXTM-I, Invitrogen, Paisley, UK 
GIBCO® RPMI 1640+GlutaMAXTM-I, Invitrogen, Paisley, UK 
    RPMI and DMEM complete: 
    + 10% FCS 
    + 1% Penicillin/Streptomycin 
    PBS: pH7.4 
    137 mM NaCl 
    2.7 mM KCl 
    10 µM Na2HPO4 
    2.0 mM KH2PO4 
     Cell dissociation buffer:  
    PBS pH 7.4 
    2mM EDTA 
    Transfection buffer (2X HBS): 
50 mM HEPES,  
10 mM KCl  
12 mM dextrose  
280 mM NaCl  
1.5 mM Na2PO4 





at 22 °C. 
    FACS buffer: 
    PBS pH 7.4 
    0.1% BSA 
    0.01% NaN3 
 
2.5 List of Antibodies used in flow cytometry (FACS) and 
western blot 
 
2.5.1 FACS antibodies 
 
Antigen Dye Clone Final 
dilution 
Supplier 
CD11b PE-Cy7 M1/70 1:2000 BD 
Biosciences 
CD206 APC 19.2 1:2000 BD 
Biosciences 
F4/80 Fitc MCA497F 1:200 BD 
Biosciences 
CD16/CD32 - 2.4G2 1:50 BD 
Biosciences 
     BD Biosciences, Heidelberg 
 
2.5.2 Western blot antibodies 
 
Antigen Clone Final dilution Supplier 





GR polyclonal 1:500 Santa Cruz 
Sirt1 polyclonal 1:1000 Sigma-Aldrich 
β-Tubulin polyclonal 1:500 ABcam 
 
2.6 Molecular biology reagents 
 
2.6.1  Enzymes used in cloning 
 
For cloning, I used the following restricted endonucleases: AgeI, XhoI, 
XbaI, EcoRI, BglII, BamHI, HindIII, KpnI, NotI, SalI and T4 ligase for 
ligation, Phusion® polymerase for mutagenesis PCR, which are all 
supplied by New England Biolabs®. 
 
2.6.2  Primers used for mutagenesis PCR 
 
Primer Sequence 
























2.6.3 shRNA sequence  
 









































































































2.6.5  Nitric oxide assay (NO assay) 
 
I used the selfmade reagents for NO assay, 1% sulfanilamide and 1% 
Naphthyl. 
 
2.6.6  Quantitative polymerase chain reaction (qPCR) 
 
I used the premix Power SYBR® Green PCR master supplied by life 
TechnologyTM. For detection gene expression, I used the following primers: 
 













Coating buffers 0.1 M sodium carbonate, pH 9.5 
Assay diluents 10% v/v FCS in PBS, pH 7.4 
Wash buffer 0.05% v/v Tween-20 in PBS, pH 7.4 
Substrate buffer 0.1 M Citric Acid, 0.2 M Na2HPO4 in 
ddH2O 
TMB solution 1% w/v 3,3 ,́5,5 -́Tetramenthyl- 
benzidine in DMSO 
Substrate solution 10% v/v TMB solution, 2% v/v H2O2 
(3.5%) in Substrate buffer 










































3.1 MRflox/flox and MRlysMcre mice 
 
All animal experiments were performed with consideration of the 
necessary legal requirements. Mice were kept under specific 
pathogen-free conditions (SPF) in individually ventilated cages (IVC). They 
were fed with food and water ad libitum and maintained in a standard 12 
hour day-night cycle.  
The generation of the MRflox/flox and MRlysMcre mice was described in Berger 
et al., 2005. The both genotypes, the exon 3 of MR gene was flanked with 
flox/flox. But only in the MRlysMcre mice, the recombinase was expressed by 
LysM promoter, which is specific for myeloid cells. Hence, in the MRlysMcre 
mice the exon 3 of MR gene is removed by recombinase leading to 
non-sufficient MR transcription, while in the MRflox/flox mice the MR gene 
transcription is not altered.  
 
3.2 Induction and analysis of EAE 
 
3.2.1  Induction of EAE 
 
Mice were immunized with 50 μg of MOG35–55 peptide in PBS, emulsified 
in an equal volume of CFA containing Mycobacterium tuberculosis H37RA 
(Difco) at a final concentration of 1mg/ml, and given s.c. into the flanks as 
previously described. Two injections of pertussis toxin (List Biological 
Laboratories; 400ng/mouse in total) were given, one immediately after 






3.2.2  Bodyweight and clinical scoring 
 
Animals were weighed and scored daily for clinical signs of the disease on 
a scale from 0 to 10 depending on its severity; scores were as followed: 0 =
normal; 1 = reduced tone of tail; 2 = limp tail, impaired righting; 3 = absent 
righting; 4 = gait ataxia; 5 = mild paraparesis of hindlimbs; 6 = moderate 
paraparesis; 7 = severe paraparesis or paraplegia; 8 = tetraparesis; 9 =
moribund; 10 = death.  
 
3.2.3  Isolation of spinal cord infiltrating macrophages 
 
EAE mice were sacrificed on day 24 with CO2 and perfused through the 
left ventricle with physiological saline (0.9%) until the effluent ran clear. 
Vertebral canal was opened with scissors and spinal cords were carefully 
taken out and subsequently rinsed in PBS. Spinal cords were forced 
through 100-mesh stainless steel screens to give a single-cell suspension. 
The spinal cord homogenate were washed with centrifuge at 500 g and 
22 °C for 20 min, after discarding supernatant pellet was resuspended in 
30% Percoll. During the wash a percoll gradient was set up with two 
concentrations, 45% and 70% percoll, in 15ml falcon. The resuspension 
was loaded on the surface of the gradient with needle carefully. The 
gradients were centrifuged at 1000 g and from 22°C cooled to 4°C for 30 
min. CNS mononuclear cells were collected from the 30%/70% interface, 
washed, and resuspended in PBS, washed, and directly lysed for RNA 
preparation. 
 
3.2.4  Immunohistochemistry 
 
EAE mice were sacrificed with CO2 and perfused through the left ventricle 





subsequently perfused with 4% paraformaldehyde. Vertebral canal was 
opened with scissors and spinal cords were carefully taken out and 
subsequently rinsed in 4% paraformaldehyde for 24 h, then rinsed in PBS. 
Spinal cord was then embedded in paraffin and cut into slide.  Spinal cord 
cross-sections were stained with Luxol fast Blue (LFB) to assess 
demyelination, macrophages/microglia by rat anti-mouse Mac-3 (BD 
Pharmingen, 1:200), T lymphocytes by anti-mouse CD3 (BD Pharmingen, 
1:200).   
 
3.3 Isolation of peritoneal macrophages (PM) 
 
Mice were interperitoneal injected with 3% thioglycolate. On the 4th day 
after injection, mice were sacrificed and the peritoneal cavity was washed 
with ice cold PBS+0.1% BSA with 2 ml for 3 times. The washed out cells 
were centrifuged at 350 g for 6 min and then resuspended and cultured in 
DMEM in 10 cm suspension culture plate, at 20 °C for 4 h. Then the 
medium and non-adherent cells were discarded and the adherent cells, 
representing mostly PMs, were incubated with enzyme free dissociation 
buffer at 4 °C for 20 min and subsequently washed off with PBS+0.1% 
BSA. The macrophages were washed again with centrifuge at 350 g for 6 
min. The pellet was resuspended in 1 ml PBS and counted.  
 
3.4 Bone marrow derived macrophages (BMDMs) 
 
3.4.1  Production of L929-cell conditioned medium (LCCM) 
 
LCCM was produced as described by Ladner et al.. In brief, L929 mouse 
fibroblasts were grown in DMEM until confluent. Then the supernatant was 





sterile and stored at -20 °C. For use, it was diluted 1:5 with DMEM (Ladner 
et al., 1988). 
 
3.4.2  Cultivation of BMDMs 
 
Mice were sacrificed with CO2. Tibia and femur were removed, cleaned 
from flesh and tendons and placed in ice cold PBS with 0.1% BSA. The 
ends of the bones were opened under sterile conditions and bone marrow 
was flushed out using a 30 G needle. Afterwards the cells were passed 
through a 40-µm cell strainer. After wash, the cells were resuspended in 30 
ml LCCM and incubated overnight in a 175 ml cell culture flask per mouse 
at 37 °C. Adherent cells were discarded and non-adherent cells were 
transferred to 10 ml suspension culture plates (5 ml cell suspension/plate). 
In each plate medium was added to 10 ml. After 5 days, another 5 ml of 
fresh LCCM were added. On day 9, the cells were washed with PBS and 
removed using 1 ml enzyme free dissociation buffer/plate and incubated at 
4 °C for 20 min. Then the cells were washed off using PBS+0.1% BSA. 
The suspension was washed at 350 g, 6 min, at 4 °C. The pellet was 
resuspended in 1 ml DMEM and counted under microscope. 
 
3.5 Phagocytosis assay 
 
On the first day, lymph nodes (lymphnodi madibulares, axillares accessorii, 
inguinales superficiales, mesenteriales) were took out from BALB/c mice 
that were sacrificed with CO2. Lymphocytes were obtained by passing the 
lymph nodes through cell strainer with a 40 µm nylon mesh. The 
lymphocytes were washed once at 350 g for 6 min at 4 °C. Then, the 
lymphocytes were resuspended in PBS with cell density of 106 cell/ml. Per 





water bath at 37 °C for 10 min. Subsequently, per ml suspension was 
added 0.02 ml FCS and centrifuged at 350 g for 10 min at 4 °C. The cell 
pellet was resuspended in 2 ml PBS and irradiated at 5 gray/min for 6 min. 
After irradiation, the cell amount was counted again and distributed in 48 
well/plate with 2x105 cell/well. Each well was filled with 500 µl DMEM. 
On the second day, macrophages were counted and at ration 2:1 
(Macrophage:lymphocyte) added to the preseeded lymphocytes. Each 
well was filled to 1 ml with DMEM and the plate was incubated at 37 °C. 
To determine the phagocytotic activity, the cell mixture was resuspended 
with Eppendorf® pipette and 500 µl mixture was took to determine the 
phagocytotic activity by FACS. On FACS, macrophage population was 
gated according to FSC and SSC. The lymphocytes should be apoptosed 
after irradiation in 24 h. 
 
3.6 Quantitative polymerase chain reaction (qPCR) 
 
3.6.1  Isolation of RNA from cells 
 
RNA was isolated using the Quick-RNATM Mini-Prep supplied by the 
Epigenetics® Company Plus Universal Kit according to manufacturer’s 
instructions. The cells were homogenized and lysed by 600 µl RTL buffer 
and subsequently centrifuged at 12,000 g for 1 min at 22 °C, through 
column supplied. Then, the column was washed once with 400 µl 
pre-wash buffer at 12,000 g for 1 min at 22 °C, and twice at 12,000 g for 30 
s at 22 °C each with 700 µl and 400 µl wash buffer containing 70% ethanol. 
Then, the column was placed in a new 1.5 ml Eppendorf® tube and 30 µl 
nuclease-free water was added into the middle of the column. After 1 min 
incubation at RT, RNA was eluted from the column by centrifuging at 






3.6.2  Reverse transcription from RNA to cDNA 
 
For cDNA synthesis the iScript cDNA Synthesis Kit was used according to 
manufacturer’s instructions. Approximately 1 µg RNA was mixed with 4 µl 
5x iScript Reaction Mix, 0.25 µl iScript Reverse Transcriptase and 14.75 µl 
nuclease-free water. The mixture was incubated at 25 °C for 5 min, 
subsequently, at 42 °C for 30 min, and finally at 85 °C for 5 min. 
 
3.6.3  Quantitative PCR (qPCR) 
 
1 µl cDNA was mixed with 12.5 µl SYBR green, 0.5 µl primer mix and 11 µl 
ddH2O in each well of a 96-well optical reaction plate. The plate was 
sealed with an optical adhesive cover and shortly centrifuged. qPCR was 
run with the applied Biosystems 7500 real time PCR system using 7500 
system SDS software. The ΔΔct was calculated automatically by the 
software. 
 
3.7 Enzyme linked immunosorbant Assay (ELISA) 
 
TNFα production by macrophages was analysed with ELISA in cell 
medium. ELISA was performed with BD Biosciences kit and according to 
manufacturer’s instructions. 
96-well plates were coated with capture antibody overnight at 4 °C using 
the appropriate coating buffer. The following steps on the second day were 
performed under RT. After washing with wash buffer, plates were blocked 
with assay diluents for 1 h. Washing was repeated and plates were 
incubated for 1 h with detection antibody and enzyme reagent diluted in 





30 s and finally the plate was incubated for 20 min with substrate solution. 
The reaction was stopped with stop solution and then measured at 450 nm 
and 570 nm. 
 
3.8 Nitric oxide assay (NO assay) 
 
NO assay was performed in 96-well ELISA plate with BMDMs. After 
harvesting BMDMs, 2x105 BMDMs were seeded in each well with 200 µl 
DMEM with LPS (0.15 ng/µl), and duplicated 4x per mouse. Two wells 
were added with 10-7 M Dex or PBS as control. The plate was incubated at 
37 °C for 48 h. Then 50 µl supernatant was transferred in corresponding 
wells in ELISA plate. Concentration series of NaNO2 solution, 500 mM, 
250 mM, 125 mM, 62.5 mM, 31 mM, 15.5 mM, 7.8 mM, 3.9 mM, 1.95 mM, 
0 mM were used to determine the NO concentration in medium. 50 µl 1% 
sulfanilamide was added to each well. After 5 min incubation, 50 µl 1% 
Naphthyl was added to each well. After gentle shaking, the plate was 
measured at 540 nm. 
 
3.9 Flow cytometry (FACS) 
 
For standard FACS-analysis 4x105 cells were used. All samples were 
analysed using a FACS Cantoll and FlowJo. If staining samples was 
necessary, samples were incubated with primary antibodies for 20 min, 
washed with 4 ml FACS buffer. After discarding supernatant, cells were 








3.10 shRNA Cloning 
 
3.10.1 Mutagenesis PCR 
 
The primers were designed by myself and synthesized by Metabion®. The 
reaction reagent was pipetted in PCR tube according to the schema below: 
Reagent Volume (µl) 
Template 0.2 
Primer forward 0.2 
Primer reverse 0.2 
Phusion® polymerase 0.5 
Invitrogen® PCR buffer 
5x 
10 
Invitrogen® dNTP 1 
ddH2O 37.9 
 
The PCR was performed in Eppendorf® thermocycler with the program: 
step Temperature (°C) Time (min) 
1 98 3 
2 98 0.5 
3 Tm* 0.5 
4 72 0.5 
5 Go to step 2, 30x  
6 72 5 
7 10 ~ 
*: the actual annealing temperature was set 1 °C higher than the lower Tm 








All ligation reactions were sticky ends ligation and performed under RT by 
using NEB® T4 ligase and the supplied ligase buffer 10x. Opened plasmid 
was mixed with cloning DNA fragment in an approximate ration of 
substance amount 1:3. Each reaction volume was set to 10 µl, including 1 
µl ligase buffer 10x and 0.5 µl T4 ligase. The rest volume was added by 
ddH2O. The mixture was than incubated at RT for 2h, and then completely 
used for transformation in E.coli. 
 
3.10.3 Plasmid amplification 
 
Plasmid was amplificated according to further experiment request either by 
mini-, midi-, or maxi-preparation. 
Mini-preparation was used for detect the positively transformed E.coli 
clone. On the second day of transformation 3-6 E.coli colonies were 
randomly picked and cultured in 3 ml anti-biotic containing LB medium at 
37 °C overnight with shaking. In the next morning, 2 ml E.coli culture was 
discarded in 2 ml Eppendorf® tube and centrifuged at 350 g for 5 min at 
4 °C. After discarding supernatant, the cell pellet was resuspended in 
self-made 300 µl P1 buffer, subsequently lysed with 300 µl P2 buffer and 
the tube was inverted 4-6 times. After 5 min incubation, 300 µl P3 buffer 
was immediately added into the tube. The tube was inverted 4-6 times and 
then placed at 4 °C for 15 min. Then the tube was centrifuged at 20,000 g 
for 15 min at 4 °C. The supernatant was collected in a new 1.5 ml 
Eppendorf® tube and added with 600 µl isopropanol. After inverting, the 
tube was centrifuged at 20,000 g for 10 min at 4 °C. Then, the supernatant 
was completely removed and 500 µl 70% Ethanol was gently added to 
wash the pellet, and immediately centrifuged at 20,000 g for 5 min at 4 °C. 





thermoblock at 65 °C. The dried pellet was dissolved in 30 µl ddH2O and 
the DNA concentration was determined by Eppendorf® Nanodrop. 
In case of midi- and maxi-preparation, appropriate kits from Qiagen® were 
used. All procedures were performed according to manufacturer’s 
instructions. The whole E.coli culture was centrifuged at 500 g for 15 min 
at 4 °C. The pellet was resuspended in 4 and 10 ml H1 buffer, and 
subsequently lysed in 4 and 10 H2 buffer, after 5 min was added with 4 
and 10 ml H3 buffer, respectively. The mixture was loaded to QIAfilter 
cartridge and incubated for 10 min at RT. Then the mixture was pushed 
through the filter into an anion-exchange tip, where the DNA was washed 
and purified. DNA elution was performed by adding 5 and 10 ml 
nuclease-free water, respectively. DNA was further purified with 
isopropanol and 70% ethanol similar to mini-preparation. 
 
3.11 Western blot 
 
Cell extracts were obtained same amount of cells and their lysis in a buffer 
containing 1% Nonidet P-40, 0.1% SDS, and 0.5% sodium deoxycholate in 
PBS. A protease inhibitor mixture was added before extraction (Roche). 
The lysates were fractionated on a SDS-PAGE gel and blotted for 1 h at 
160 mA using a semidry device. Western blot analysis was performed by 
antibody incubation in PBS containing 0.1% Tween and 5% (w/v) BSA on 
shaker at RT. The following primary antibodies were used in this study: 
anti-MR (ABcam, 1:1,000 dilution), Sirt1 (Sant Cruz; 1:1,000 dilution), GR 
(Santa Cruz, 1:1,000 dilution). Goat anti-rabbit IgG-HRP and goat 
anti-mouse IgG-HRP (Dianova) were used as secondary antibodies and 







3.12 Cell culture 
 
3.12.1 HEK293 cell culture 
 
HEK293 cells were cultured in DMEM in culture dish. After 80% confluent 
the cells were detachted with trypsin, 0.5 ml and 1 ml for 5 cm and 10 cm 
dish, respectively. The cells with trypsin were incubated at 37°C for 1 min 
and immediately washed with 10 ml DMEM. After centrifugation the cell 
pallet was resuspended with 10 ml DMEM and placed 1 ml in a new dish 
with 9 ml fresh medium. 
 
3.12.2 Generation of MR overexpressing cells 
 
I used HEK293 cells for generating MR overexpressing cells. MR cDNA 
was cloned in pcDNA3 plasmid. Ca3(PO4)2 precipitation was used to 
transfect the MR encoding vector into HEK293 cells. 106 HEK293 cells 
were seeded in 6 cm dish in 4 ml transfection medium and incubated at 
37 °C for 4 h. 20 µg MR containing vector was mixed with Na2HPO4 (pH 
6.8) and added with ddH2O to 500 μl, and subsequently dropwise mixed 
with 500 μl 50 mM CaCl2 accompanying vortex. Subsequently, the mixture 
was equally distributed to the cells and incubated at 37 °C overnight. On 
the second day, medium was replaced by 5 ml fresh BMDM. After 
confluent, cells were detached, washed and resuspended in 40 ml fresh 
BMDM with 3 µg/ml puromycin, then, distributed in two 98-well tissue 
culture plates. Since the 3rd weed, only the cell colonies, which were as the 
single colony in well and observed by naked eye, were detached and 
expanded in 6-well tissue plate with 2 ml fresh BMDM with 3 µg/ml 
puromycin. The medium with antibiotic was replaced every day. After 





expression, and the rest of cells were cultured further in new plate. 
Following, only the cell clone that expressed the most MR protein was 
reserved for the MR knockdown test.   
 
3.12.3 C2C12 cell culture 
 
C2C12 cells were cultured in DMEM in culture dish. After 80% confluent 
the cells were detachted with trypsin, 0.5 ml and 1 ml for 5 cm and 10 cm 
dish, respectively. The cells with trypsin were incubated at 37 °C for 1 min 
and immediately washed with 10 ml DMEM. After centrifugation the cell 
pallet was resuspended with 10 ml DMEM and placed 1 ml in a new dish 
with 9 ml fresh medium. 
 
3.12.4 Mouse embryonic fibroblast (MEF) 
 
MEF cells were cultured in DMEM in culture dish. After 80% confluent the 
cells were detachted with trypsin, 0.5 ml and 1 ml for 6 cm and 10 cm dish, 
respectively. The cells with trypsin were incubated at 37 °C for 1 min and 
immediately washed with 10 ml DMEM. After centrifugation the cell pallet 
was resuspended with 10 ml DMEM and placed 1 ml in a new dish with 9 
ml fresh medium. 
 
3.13 Procedures with lentivirus (Under S2 condition) 
 
3.13.1 Lentivirus production 
 
Lentiviral particles were produced by transfecting HEK293 cells seeded in 





precipitation, 10 μg of vector DNA together with three helper plasmids (5 
μg of pMDL-RRE, 2.5 μg of pRSV-REV, and 3 μg of pVSV-g, all the 
amounts are portioned for one dish.) were mixed with Na2HPO4 (pH 6.8) 
and added with ddH2O to 500 μl. 500 μl 50 mM CaCl2 was dropwise added 
to the mixure accompanying vortex. Subsequently, the precipitation was 
added to HEK293 cells. After 8h, the medium was aspirated with 4 ml fresh, 
prewarmed medium and added with 8 μM butyrate. The virus-containing 
cell culture supernatants were collected 48 h after transfection, passed 
through a 0.45-μm filter, and be ready for direct knockdown test in cell 
culture or further ultraconcentration. 
 
3.13.2 Concentrating lentivirus by Ultracentrifugation 
 
The virus-containing cell culture supernatants were collected 48 h after 
transfection, passed through a 0.45-μm filter, and concentrated by 
centrifugation in Beckermann® Tube, filled with medium to remove the 
bubbles, for 2 h at 26,000 g at 4 °C. The virus pellet was subsequently 
resusupended in 10 μl of PBS/0.1% BSA for 48 hours and subsequently 




In order to circumvent the freezing-thawing influence on virus infectious 
ability, to all titration tests the virus was first treated once through 
freezing-thawing. On the titration day, 104 HEK293 cells/well were seeded 
in 12-well plate. For each viral construct, six wells are required. After 
thawing, the virus aliquot was 1:100 diluted and titrated to the cells in 
volumes: 300 µl, 100 µl, 30 µl, 10 µl, 3 µl, 1 µl. Then the plate was 
incubated at 37 °C for 3 days. On the 3rd day after titration, the cells were 





Subsequently, the EGFP positive cell population was determined by 
FACS. 
 
3.13.4 shRNA functional test in vitro 
 
3 ml filtrated virus-containing medium was mixed with 1 ml fresh DMEM 
and added to C2C12 cells, MR overexpressing HEK293 cells and MEF 
cells for shSirt1, shMR and shGR test, respectively. Four days after 
infecetion cells were detached, and the half cells were used to be analyzed 
for infection ratio by FACS. The cell population over 80% infected was kept 
in culture for further test. Till confluent, cells were splited in two 6 cm 
dishes. One dish was treated with Doxycycline to concentration 2 µg/ml, 
the other one was treated with PBS as control. Medium and regency were 
aspirated every day. After three days treatment, the cells were detached 
and counted. The same amount cells were lysed as described in “Western 
















4.1 Characterization of bone marrow derived macrophages 
(BMDMs) in MRlysMcre mice 
 
4.1.1  Efficiency of MR ablation in macrophages 
 
In order to check the MR knockout efficiency in used BMDMs population 
the levels of MR mRNA from the cells harvested from BMDMs culture were 
compared with qPCR (Figure 2). I compared the MR gene expression in 
MRlysMcre and MRflox/flox samples by setting the later one’s mean value as 
100%. The MR gene expression was strongly reduced in MRlysMcre 
samples, around 80% less than in MRflox/flox samples. 
 
                   
Figure 2: The MR knockout efficiency in BMDMs. Mouse bone marrow was 
resuspended and cultured in LCCM for differentiation to BMDM; After 8 days RNA was 
isolated from the differentiated BMDMs and reverse transcribed to cDNA; The expression 
levels of MR mRNA were measured by qPCR using primers, which bind to the junction 
between exon 3 and exon 4; the relative mRNA expression levels were obtained by 
normalizing to HPRT mRNA expression; relative expression in MR
flox/flox 





100%; mean values + s.e.m (n=5). 
 
4.1.2  Relative expression levels of macrophage-specific genes in 
BMDMs 
 
To test the effect of myeloid specific MR ablation on fresh derived 
macrophage polarization, I investigated the gene expression pattern in 
BMDMs in vitro (Figure 3A, B, C). The BMDMs of both genotypes have 
similar expression pattern of AAM markers (Figure 3A) and typical 
proinflammatory cytokines (Figure 3B). Due to the opposed functions of 
Arginase1 and iNOS in macrophagesthe, I also compared the expression 
of these two genes (Figure 3C). Arginase1 gene was nearly equally 
expressed in both macrophage genotypes. Interestingly, the iNOS gene 










Figure 3: Relative expression levels of macrophage-specific genes. Mouse bone marrow was 
resuspended and cultured in LCCM for differentiation to BMDM; After 8 days RNA was isolated from 
the differentiated BMDMs and reverse transcribed to cDNA; relative mRNA expression levels were 
obtained by normalizing to HPRT mRNA expression; relative expression in MR
flox/flox
 was set equal 
to 1; mean values + s.e.m (n=11-13). The relative expression levels of anti-inflammatory genes (A) 
and pro-inflammatory genes (B) in MR
lysMcre
 macrophages are compared to that in MR
flox/flox 
macrophages. To highlight the difference between the two genotypes, the relative expression levels 
of Arginase1 and iNOS are depictured together (C). 
 
4.1.3  Phagocytosis assay 
 
To investigate the effect of the myeloid specific MR knockout on the 
phagocytotic activity of BMDMs, I performed a phagocytosis assay by 
mixing BMDMs with CFSE stained and subsequently irradiated lymph 
nodes cells. After taking up the lymph nodes cells, the BMDMs acquired 





BMDMs contained a higher CFSE positive population than the MRflox/flox 
BMDMs, suggesting that the MRlysMcre BMDMs took up more apoptotic 
lymph node cells than MRflox/flox BMDMs did. 
 
               
Figure 4: Phagocytotic activity of BMDMs. BMDMs were mixed with CFSE prestained cells 
isolated from lymph nodes at a ratio of 2:1 (BMDMs:cells); The cell mixtures were collected after 2h, 
subsequently measured by flow cytometry; the percentages of CFSE positive macrophages from 4 
separated experiments (n=20-22) were determined and depictured in this graph. 
 
4.1.4  TNFα production by BMDMs after LPS stimulation 
 
AAMs generally have lower expression of proinflammatory cytokines 
compared to CAM. To address whether myeloid cell-specific MR ablation 
polarizes macrophages towards an anti-inflammatory state, I stimulated 
BMDMs with LPS for 48h with or without Dex treatment and measured 
TNFα production by these cells in vitro (Figure 5). As illustrated, Dex 
significantly reduced the TNFα production by BMDMs of the both 
genotypes compared to the group without Dex treatment. The MRlysMcre 
BMDMs produced almost equal amount of TNFα alone upon LPS 
stimulation. But after Dex treatment, TNFα production by MRlysMcre BMDMs 






              
Figure 5: TNFα produced by BMDMs after LPS stimulation. BMDMs were cultured with Dex 10
-7 
M or PBS as a control, and stimulated with LPS (3ng/mL). Supernatants were collected after 48h 
stimulation and TNFα was measured by ELISA; mean values + s.e.m, (n=4-6). 
   
 
4.1.5  NO Production by BMDMs after LPS stimulation 
 
One of the characteristics of AAM is a higher expression of Arginase1, 
which competes with iNOS for the substrate L-arginine. The more 
L-arginine that is converted by Arginase1 to urin and ornithine, the less NO 
can be produced by iNOS from L-arginie. To address whether MRlysMcre 
macrophages acquired this AAM property, I assessed NO production by 
BMDMs of both genotypes (Figure 6). Similar to the TNFα production 
pattern, NO production by both genotypes was strongly reduced after Dex 
treatment. However, MRlysMcre BMDMs produced significant less NO than 






              
Figure 6: Production of NO by BMDMs after LPS stinulation. BMDMs were cultured with or 
without 10
-7
M Dex in 96-wells plate and stimulated with 3ng/mL LPS; Supernatant was collected 
after 48h stimulation and the NO concentration was measured by using the “Griess Reagent system” 
(n=10-12).  
 
4.1.6  Relative gene expression of Arginase1 and iNOS in BMDMs 
after LPS stimulation 
 
I isolated mRNAs from the BMDMs after 48h stimulation and compared the 
mRNA levels of Arginase1 and iNOS in both genotypes (Figure 7). The 
MRlysMcre BMDMs expressed more Arginase1 and less iNOS in compared 
to those by MRflox/flox after LPS stimulation. Despite the differences 
between the two genotypes were not significant, regarding to the opposed 
effects of these two genes an aggregated effect on NO production could 
be enormous. 





              
Figure 7: Relative gene expression of Arginase1 and iNOS in BMDMs after LPS stimulation. 
RNA was isolated from the BMDMs after LPS stimulation and reverse transcript to cDNA for qPCR; 
relative mRNA expression levels were obtained by normalizing to HPRT mRNA expression; mean 
values + s.e.m (n=11-13).  
 
4.2 Characterization of peritoneal macrophages (PMs) in 
MRlysMcre mice 
 
4.2.1  Relative expression levels of macrophage-specific genes in 
PMs 
 
To test the effect of MR deletion on PM polarization, I investigated genes 
expression pattern in vitro (Figure 8A, B, C). P.M.s of both genotypes had 
similar expression patterns of AAM markers (Figure 8A) and typical 
proinflammatory cytokines (Figure 8B). Due to the opposing functions of 
Arginase1 and iNOS in macrophages, I also compared gene expression of 
these two genes (Figure 8C). In contrast to BMDMs, MRlysMcre P.M.s 








Figure 8: Relative gene expression in PMs. Thiglycollate elicited PMs were collected from 
peritoneal cavity on day 3 after Thioglycolate injection and used for RNA isolation; the relative 
mRNA expression levels of AAM markers mRNA were obtained by normalizing to HPRT mRNA 
transcription; relative expression in MR
flox/flox 
was set equal to 1; mean values + s.e.m, (n=10-12). 
The relative expression levels of anti-inflammatory genes (A) and pro-inflammatory genes (B) in 
MR
lysMcre
 macrophages are compared to that in MR
flox/flox 
macrophages. To highlight the difference 
between the two genotypes, the relative expression levels of Arginase1 and iNOS are depictured in 
one graph (C). 
 
 
4.2.2  Phagocytosis assay of PMs 
 
I performed a phagocytosis assay by mixing PMs with lymph nodes cells, 
which were CFSE stained and subsequently irradiated. After taking up the 
lymph nodes cells, the macrophages acquired CFSE and were counted by 





CFSE positive population than MRflox/flox macrophages, and the difference 
between both genotypes was statistically significant, suggesting that MR 
deletion enhanced the phagocytotic activity in macrophages. 
 
                  
Figure 9: Phagocytotic activity of PMs. Thioglycollate elicted PMs were collected from the 
peritoneal cavity and mixed with CFSE prestained cells isolated from lymph nodes at a ratio of 2:1 
(BMDMs:cells); The cell mixtures were collected after 20h and subsequently measured by flow 
cytometry; the percentages of CFSE positive macrophages from 2 independent experiments (n=6-7) 
were determined and depictured. 
 
4.3 Characterization of EAE in MRlysMcre mice 
 
4.3.1  EAE clinical disease curve 
 
In vitro experiments had shown that MR knockout macrophages acquired 
some AAM characteristics. To address the question whether MRlysMcre mice 
benefit from myeloid specific MR ablation in vivo, we chose the EAE 
disease model. We induced EAE in both MRflox/flox and MRlysMcre mice with 
MOG35-55 and CFA. Around 7 days after induction we observed first 
disease symptoms and then scored the mice every day (Figure 10). In the 
first acute phase the mice from both genotypes EAE developed almost 





(from 14th day to the end), the disease did not aggregate anymore and 
even slightly recovered in some individuals. In this phase, the MRlysMcre 
mice suffered significantly less from EAE than the MRflox/flox mice. 
 
             









mice using MOG on day 0 and twice injected with Pertussis; the clinical 
scores were record every day and illustrated on this graph; the experiment was independently 
repeated 3 times (n=23-29).  
 
4.3.2  Relative expression levels of AAM markers in PMs from EAE 
mice 
 
At the end of EAE experiments I sacrificed the mice and isolated their P.Ms. 
Gene expression in these cells was compared by qPCR. Here I compared 
the gene expression of AAM markers in PMs between both genotypes. 
The MRlysMcre PMs expressed significantly more AAM markers compared 
to the MRflox/flox PMs, which was not observed in PMs from healthy mice of 
both genotypes (Figure 11). 





                
Figure 11: Relative gene expression in PMs from EAE mice. The PMs were elicited from 
peritoneal cavity of EAE mice 92h after thioglycolate injection; RNA was isolated from the cells and 
reverse transcript to cDNA; relative expression levels of AAM markers mRNA were obtained by 
normalizing to HPRT mRNA expression; relative expression in cells from MR
flox/flox
 mice was set 
equal to 1; mean + s.e.m. (n=16-18). The relative expression levels of anti-inflammatory genes in 
MR
lysMcre




4.3.3  Relative expression levels of AAM markers in spinal cord 
infiltrating cells from EAE mice 
 
At the end of EAE experiments we sacrificed the mice and isolated the 
infiltrating cells from their spinal cords. Gene expression in these cells was 
compared by qPCR. Since Arginase1 and iNOS are two competitors in 
producing NO in macrophage, their gene expressions were compared 
(Figure 12C). The two genotypes showed completely different expression 
pattern. In the cells from MRlysMcre mice expression of Arginase1 was 
significantly higher than in those from MRflox/flox mice, while the pattern of 
iNOS expression was inverted. This observation may reflect a strongly 
reduced NO production in MRlysMcre mice during the chronic phase of 
EAE. I also compared gene expression of the AAM markers (Figure 12A). 





macrophages, their expression in the infiltrating cells could reflect the 
polarization of macrophages. The cells from MRlysMcre mice expressed 
these genes slightly more than those from MRflox/flox mice. Meanwhile, 
the gene expression of proinflammatory cytokines was simimlar between 
both genotypes (Figure 12B). 
 
 
Figure 12: Relative gene expression levels in spinal cord infiltrating cells from EAE mice. 
The spinal cord infiltrating cells were isolated from EAE mice by percoll gradient; RNA was isolated 
from the cells and reverse transcript to cDNA; relative expression levels of AAM markers mRNA 
were obtained by normalizing to HPRT mRNA expression; relative expression in cells from MR
flox/flox
 
mice was set equal to 1; mean + s.e.m. (n=16-18). The relative expression levels of 
anti-inflammatory genes (A) and pro-inflammatory genes (B) in MR
lysMcre
 macrophages are 
compared to that in MR
flox/flox 
macrophages. To highlight the difference between the two genotypes, 







4.3.4  Histological analysis of EAE mice 
 
Next, I investigated whether the amelioration of EAE correlated with 
improved histopathologic features. In MRlysMcre mice, the macrophage 
infiltration in total spinal cord and white matter (Figure 13A left and right) 
was significantly reduced compared with that in MRflox/flox mice, whereas 
the T lymphocytes infiltration in total spinal cord and white matter (Figure 
13B left and right) was not altered in both genotypes.  
A striking accordance to the clinical scoring data, the myelin sheath in 
MRflox/flox mice was more dramatically damaged and more litter debris 

















          
         
 
            
Figure 13: Histological analysis of spinal cord from EAE mice. A) The infiltrating macrophages 
in total spinal cord (left) and white matter (right) were stained with Mac3 antibody and determined 
as macrophages/mm
2
 on ImageJ; this ratio was then depictured; B) the infiltrating T lymphocytes in 
total spinal cord (left) and white matter (right) were staind with anti-CD3 antibody and determined as 
T lymphocytes/mm
2
 on ImageJ; this ratio was then depictured; C) The myeline sheath was stained 












4.4 Generation of inducible and reversible knockdown 
mouse models 
 
4.4.1  Simplifying the cloning procedure 
 
Cloning of the shRNA sequence is the first important step necessary for 
using the inducible and reversible gene knockdown system. The basic 
principle of the previous protocol was as follows: The oligos containing the 
shRNA sequence are annealed, phosphorylated and cloned into the BbsI 
and XhoI sites of pH1tet-flex; in this vector the fragment spanning from the 
H1tet-Promoter to the end of the shRNA sequence is amplified and 
extended by a PacI tag on both ends using mutagenic primers; after 
digesting, the PCR fragment can be cloned into the FUTG vector, in which 
the second cassette of the system was already placed; however the last 
step is practically difficult to perform and a bypass through the vector 
pBluesript was mostly required. The whole cloning protocol takes a long 
time and the difficult cloning steps always used to be repeated for the 
cloning of each shRNA sequence. Since the new system is interested to 
be a common method for making a gene knockdown it was necessary to 
simplify the cloning protocol. The underlying principle was to generate a 
vector in which the H1tet-promoter and the second cassette were already 
placed by leaving cloning sites for the shRNA, so that later after annealing 
and phosphorylating any other shRNA sequence can be cloned in one step 
into the final vector (Figure 14A, B).  
In order to archive the goal I first modified the BbsI site to AgeI, because 
the BbsI of the old cloning sites was not unique in the final vector (Figure 
14A, C1-2). After replacement of the old H1tet-promoter with the modified 
one I cut the fragment spanning from SalI to XhoI out and cloned it into the 





The XhoI and AgeI were now unique in the new vector, named 
FH1UTG-AgeI new and ready for further shRNA cloning (Figure 14B). 
Because of the abnormal recognition site of BbsI the last six bases in the 
H1tet-promoter would have been removed during cloning, which does no 
longer occur after modifying it from BbsI to AgeI. Hence I removed the last 
six bases by mutagenic PCR, without altering the transcription activity of 
the promoter (Figure 14C2-3). By completing this step the new one step 























Figure 14: Schema of the cloning strategy. A) The cloning sites for the shRNA were mutated 
from BbsI-XhoI to AgeI-XhoI; the segment between SalI and XhoI was cut out for next step; B) The 
segment from the vector pH1tet-flex was cloned into the vector FUTG at the XhoI site, upstream of 
the second cassette of the inducible and reversible gene knockdown system. The new vector was 
called “FUTG-AgeI new”; C) All sequences represent the sequences of the H1tet-promoter and the 
shRNA cloning sites; the bases in boldface represent the whole H1tet-promoter region, and the 





second sequence is the sequence after transforming from the BbsI recognition sequence to the 
AgeI recognition sequence; the third sequence represents the sequence after modifying the 
H1tet-promoter region. 
 
4.4.2  Cloning of shMR, shGR and shSirt1 sequences 
 
I cloned one shGR sequence, five shMR sequences and four shSirt1 
sequences (see Material 2.6.3) into the “FH1UTG-AgeI new”. As shown in 
Figure 14B, I left the AgeI and XhoI sites for shRNA cloning. After cloning 
the fragment between EcoRI and XhoI was around 60bp, which represents 
the length of shRNA sequence, longer than the fragment before the 
cloning. This 60 bp difference could be directly observed on a 1% agarose 
gel (Figure 15). 
 
                        
Figure 15: Verifying the plasmids containing the cloned shRNAs. The colonies on the selection 
plate were expanded in selection LB medium; the plasmids were isolated and digested by EocRI 
and XhoI, then loaded on 1% agarose gel. The segment cut from the plasmid containing the shRNA 
(here shGR is given as an example) was compared to the one from the empty plasmid, the right and 





4.4.3  Titration of lentivirus with shRNA 
 
For successful virus injection into zygotes, we need highly concentrated 
viruspreparation (107-108 TU/mL). After ultra centrifugation I identified the 
viral concentrate by titrated infection of HEK293 cells. After 48h I identified 
the infected cells on the basis of EGFP expression by FACS. The 
percentage of GFP positive cells in relationship to the volume of virus 
(after 1:100 dilution) is depictured (Figure 16A). The curve in the smaller 
volumes region (1-10 µL) revealed a lineage relationship between GFP 
positive cells and the volume of virus which means in range of these 
volumes almost each target cell had been infected by a unique lentivirus 
(Figure 16B). Depicting this region in a new graph, I calculated the TU/mL 
using the trend line to be around 3*107 TU/mL, which corresponds to the 
lower range of sufficient viral concentration for zygote injection. 
 
 
Figure 16: Titration of a lentivirus containing a shGR. The “Volume of Virus” refers to the 
volume of the 1:100 dilution of virus concentrate; the tested volumes included 1µL, 3µL, 10µL, 30µL, 
100µL and 300µL; the virus was incubated with HEK293 cells for 2 days; the infected HEK293 cells 
were determined by flow cytometry; A) values were connected by a smooth curve; B) the regression 
curve of the first three values represents the “linear region”, in which the percentage of infected 







4.4.4  shRNA functional test in vitro 
 
To identify the knockdown efficiency of the shGR in the new lentiviral 
construct, I infected MEF cells with the lentiviruses. Then I treated the cells 
with 2ug/mL Doxycycline for 3 days to induce the shGR expression, and 
equal amount PBS as control. Before harvesting the cells I identified the 
infected cell population by EGFP expression (Figure 17A). The FACS data 
showed over 90% of infected cells, which excluded the possibility that a 
low protein knockdown efficiency was caused by a low infection rate. Then 
I identified the GR knockdown by western blot (Figure 17B). After 
Doxycycline treatment the GR had almost disappeared in contrast to PBS 
treatment, indicating that the shGR in the new plasmid allowed efficient 














Figure 17: Test of the inducible knockdown using the shGR lentivirus in MEF cells. The shGR 
transfected MEFs were cultured with 2ug/mL Doxycycline (+) or an equal amount of PBS (-) as a 
control, for 3 days; from the cultures some cells were directly used to identify the percentage of 
positive transfecet cells by flow cytometry and compared to non-infected cells (A), the lysates from 
the rest of the cells were loaded on a SDS-PAGE gel for western blot; an anti-β tubulin antibody was 
used as loading control (B). 
 
In case of the shMR, we have neither a verified shMR sequence nor 
mouse MR expressing cell line in culture. So I first generated the mouse 
MR overexpressing cells by transfecting the mouse MR cDNA via the 
pCDNA vector by using Ca3(PO4)2 precipitation. After several weeks, I 





kidney lysate from mice (Figure 18A) by western blot, and the lysate from 
leber was used as a negative control. The western blot showed the MR 
band from HEK293 cells at a similar position compared with the 
endogenous MR in kidney.  
After accomplishing the MR overexpressing cells, I cloned five different 
sequences into the new plasmid and generated lentiviruses, then infected 
HEK293 MR overexpressing cells. I treated the cells with 2ug/mL 
Doxycycline for 3 days to induce the shRNA expression, and equal amount 
PBS as a control. Before harvesting the cells I identified the infected cells 
by EGFP expression (Figure 18B). The FACS data showed the cell 
populations for each shMR sequence were almost equally infected, which 
excluded the possibility of low protein knockdown efficiency caused by a 
low infection rate. Then I identified MR knockdown efficiency of those 
candidates by western blot (Figure 18C). After Doxycycline treatment the 
4th shMR sequence demonstrated the most reliable MR knockdown 
efficiency compared to the other sequences. 
   
 
 















       
 
         








overexpressing HEK293 cells. A) the MR overexpressing HEK293 cells were generated by 
transfecting mouse MR cDNA via pCDNA3 vector; after clone selection, the cell lysate was 
compared with the positive control (+), kidney lysate from mice, and the negative control (-), leber 
lysate from mice; B) The percentage of infected cells were quantified by flow cytometry and 
compared to non-infected cells; C) The shMR transfected cells were cultured with 2ug/mL 
Doxycycline (+) or an equal amount of PBS (-) as a control, for 3 days; the lysates from the rest of 
cells were loaded on a SDS-PAGE gel for western blot; analysis the blot was incubated with anti-β 
tubulin as a loading control. 
 
As in the case of shMR, we did not have a verified shSirt1 sequence. So I 
first cloned four different sequences into the new plasmid and generated 
lentivirus, then infected C2C12 cells. I treated the cells with 2 µg/mL 
Doxycycline for 3 days to induce the shRNA expression or an equal 
amount of PBS as a control. Before harvesting the cells I identified the 
infected cells by EGFP expression (Figure 19A). The FACS data showed 
thath the cell populations for each shSirt1 sequence were almost equally 
infected, which excluded the possibility of low protein knockdown 
efficiency caused by a low infection rate. Then I identified the Sirt1 
knockdown efficiency of those candidates by western blot (Figure 19B). 
After Doxycycline treatment the 3rd shSirt1 sequence leads to the stronger 
Sirt1 knockdown efficiency compared to the other sequences. 
 






        
Figure 19: Test of the inducible knockdown using four shSirt1 sequences in C2C12 cells. A) 
The percentage of infected cells was quantified by flow cytometry and compared to non-infected 
cells; B) The shSirt1 tranfected cells were cultured with 2ug/mL Doxycycline (+) or an equal amount 
of PBS (-) as a control, for 3 days; the lysates from the rest of cells were loaded on a SDS-PAGE gel 










4.4.5  Functional test of the shGR knockdown 
 
In order to functionally verify the knockdown of the GR, I investigated the 
GR target gene expression. Due to further treatment on the cells, I did the 
first test to exclude the effects of the further treatment on GR knockdown 
(Figure 20). After addition of Doxycycline the shGR was highly efficient in 
reducing GR mRNA levels compared to PBS, and independently of the 
treatment with Dex, PMA or both. MEF gr-/- cells were used as a positive 
control. 
 
             
Figure 20: Test of the GR knockdown efficiency achieved by using the shGR lentivirus. The 
shGR transfected MEF cells were incubated with Dox (2µg/mL) or an equal amount of PBS for 3 
days; MEF gr
-/-
 cells were used as control; cells were additionally treated with either Dex (10
-7
 M) or 
PMA, or both; RNA was isolated from cells and reverse transcript to cDNA; relative expression level 
of GR mRNA was obtained by normalizing to HPRT mRNA; mean + s.e.m. (n=4). 
 
I chose two genes, GILZ and IL6, to test the physiological function of the 
GR knockdown, because they were regulated by GR in opposing 
directions. GILZ expression is upregulated by GR activation. After 
administration of GC derivate Dex, only in MEFs with shGR and PBS, 
GILZ expression was elevated, while in MEFs with shGR and Dox, GILZ 





A). IL6 expression is downregulated by GR activation and upregulated by 
protein kinase C (PKC). So I induced IL6 expression with PMA, an 
activator of PKC. PMA treatment enhanced slightly in all three cell groups 
the IL6 expression (Figure 21B). After addition of Dex, only in MEFs with 
shGR and PBS, IL6 expression was robustly reduced, whereas it 
maintained in the other two groups, MEFs with shGR and Dox and MEF 
gr-/-. 
 
            
             
Figure 21: Functional tests of GR knockdown efficiency by using shGR lentivirus. The shGR 
transfected MEF cells were incubated with Dox (2 µg/mL) or an equal amount of PBS for 3 days; 
MEF gr
-/-
 cells were used as a control; A) cells were additionally treated with Dex (10
-7
 M) or equal 
amount PBS; B) cells were additionally treated with either PMA or PMA + Dex (10
-7
 M), or an equal 
amount of PBS; RNA was isolated from cells and revers transcript to cDNA; relative expression 







4.4.6  Test of transgenic mice 
 
The virus was injected into two-cell stage embryos and transferred into the 
oviduct of peseudopregnant female mice.  From these femals we got 8 
offsprings. We took tail blood from the offsprings and identified the EGFP 
expression (Figure 22A). We got four candidates having high EGFP 
expression level in cells. The cells from mouse 2, 5, 8 showed obvious 
high percentage of EGFP positive cells, over 90%, suggesting that in these 
mice the integration of shMR containing lentiviral vector was successful 

























   
 


























































Figure 22: Test of transgene integration in offspring from transgenic mice. A) The blood from 
tails of 3 weeks old mice was collected; either the whole blood cells or pure lymph cell population 
were measured by flow cytometry and gated for EGFP positive cells; B) RNA was isolated from the 
rest of the blood cells and reverse transcript to cDNA; the successful integration of the lentiviral 
construct was determined on agarose gel after PCR with primer pair “FUTG rettung”; the 1
st
 lane 




 lanes were loaded with PCR samples of 
mouse 1 to 8, correspondingly, the 10
th
 lane was loaded with PCR sample of water, as a negative 
control (-), the 11
th
 lane was loaded with PCR sample  of the lentiviral construct, as a positive 
control (+). 
 
To further verify the successful integration of the lentiviral construct, we 
isolated the RNA from the rest of the blood cells and reverse transcript to 
cDNA. Then, I performed PCR with primer pair “FUTG rettung”: (forward) 
5’-GCGTTCGAATTCCATGGGTCGAGTTAATTA-3’ and (reverse) 5’-ATTA 
ACTCGAGTCTAGACCTAGACCGGTTCTCTATCACTGATAGGGACTTAT
AAGATTCC-3’ (Figure 22B). Although the primer pair was previously 







cloning the last over 30 bp in the reverse primer are still complementary to 
the sequence in our lentiviral construct. The amplified bands revealed the 
successful integration of lentiviral construct in the offsprings, and in some 
degree their intensity corresponded to the EGFP positive cell population 


























5.1 Effect of myeloid cell-specific ablation of MR on 
macrophages polarization 
 
Macrophages play an essential role in innate and adaptive immune 
defense. Recently, the functional heterogeneity of macrophages attracted 
many focus because of its importance in homeostasis in immune 
responses and the chronic inflammatory diseases as consequence of the 
homeostasis disorder. Analogous to the Th1 and Th2 dichotomy of T cell 
polarization, macrophages can be polarized by the microenvironment to 
mount specific M1 or M2 functional programs (Gordon, 2003). Classic or 
M1 macrophage activation in response to microbial products or IFN-γ is 
characterized by high capacity to present antigen; high IL-12 and IL-23 
production and consequent activation of a polarized type I response; and 
high production of nitric oxide (NO) and reactive oxygen intermediates. 
Thus, M1 macrophages are generally considered potent effector cells that 
kill intracellular micro-organisms and tumor cells and produce copious 
amounts of proinflammatory cytokines. In contrast, alternative activation of 
macrophages is promoted by various signals, such as IL-4, IL-13, GCs, 
IL-10, Ig complexes/Toll-like receptor (TLR) ligands that elicit different M2 
forms, able to tune inflammatory responses and adaptive Th2 immunity, 
scavenge debris, and promote angiogenesis, tissue remodeling, and 
repair (Mantovani et al., 2002). 
The activated PPARγ can also polarize macrophages towards alternatively 
activated state and partially overlaps that activated by GR (Caglayan et al., 
2008). On the other hand, the effect of MR antagonists in mitigating 





that of activation of PPARγ by pioglitazone (Usher et al., 2010; Blasi et al., 
2003). To address the effect that a myeloid cell-specific MR knockout has 
on macrophage polarization, I compared the AAM characteristics between 
both genotypes. In both BMDMs and PMs, the AAM markers expression 
(Mantovani et al., 2004) by MRlysMcre macrophages was even or equal to 
that by MRflox/flox macrophages. The production of NO, which is respond for 
oxidative stress and tissue damage (Farias et al., 2007; Aboul-Enein et al., 
2006) was only potentially reduced, according to the significantly less 
iNOS expression by MRlysMcre BMDMs than that by MRflox/flox BMDMs. The 
nearly undistinguishable markers expression pattern in BMDMs between 
both genotypes was also observed by the other group (Frieler et al., 2011) 
and can be a consequent of that all the BMDMs were freshly derived from 
bone marrow myeloid cells in cell culture, thereby in an inactivated status. 
However, the iNOS expression was different in BMDMs between both 
genotypes. A possible explanation could be that the iNOS can be more 
directly regulated by MR (Takeda, 2004) than the other inflammatory 
genes, thereby a minor level of GCs or MCs in the used medium can via 
MR elevate the iNOS expression. Additionally, low concentration of GC 
can also induce iNOS expression via GR in macrophages (Haigis et al., 
2006). In case of PMs, they were elicited from healthy mice so that similar 
to those freshly derived BMDMs they did not exert difference in gene 
expression. GR signaling can elevate phagocytosis of apoptotic cells by 
macrophage (Lui et al., 1999), and MR and GR have largely opposing 
effect on macrophages (Lyons et al., 2007), thereby the possible MR 
signling activated by GCs in serum can reduce the phagocytotic activity of 
macrophage.The phagocytosis of apoptotic cells by macrophage is a 
much complicated process, which involves many cell surface molecules 
including lectins (Duvall et al., 1985), αvβ3 integrin/CD36/thrombospondin 
complex (Savill et al., 1990; Savill et al., 1992), phosphatidylserine 





receptors for oxidized lipids (Chang et al., 1999), CD14 (Devitt et al., 1998), 
CD29 (Schwartz et al., 1999), the ABC1 transporter (Luciani et al., 1996), 
and receptors for complement components C3bi (CR3/CR4) (Mevorach et 
al., 1998) and C1q (Botto et al., 1998). To further determine how MR 
knockout enhances the phagocytotic capacity of macrophage, the 
expression of these molecules under MR knockout condition should be 
invetigated.  
The difference between both genotypes appeared mainly after LPS 
stimulation. Regardless of addition of dexamethasone, MRlysMcre BMDMs 
produced less NO and TNFα than MRflox/flox ones. Noticeable is that the 
productions of NO and TNFα by MRlysMcre BMDMs were strongly reduced 
as well as those by MRflox/flox BMDMs. Furthermore, the gene expression 
levels of Arginase1 and iNOS differentiated towards two distinct directions 
in both genotypes. MRlysMcre BMDMs expressed more Arginase1 and less 
iNOS than MRflox/flox BMDMs did. Though the difference was not significant, 
combining the opposing directions could contributed to a strong decline of 
NO production, consisting with the observation of NO production. These 
imply that the less productions of NO and TNFα by MRlysMcre BMDMs 
rather resulted from MR knockout than a GR- related anti-inflammatory 
effect, because as reported the activation of PPARγ can inhibit toll-like 
receptor mediated activation of myeloid cells via MAP kinase and NF-κB 
pathways, by which the LPS induced the inflammatory response by 
macrophage (Silke et al., 2004), both activation of PPARγ and MR 
antagonist mitigated inflammatory responses (Iglarz et al., 2003; Caglayan 
et al., 2008). This finding is consistent with the data of the other groups by 
using PPARγ agonist (Ogawa et al., 2005). Their data show that in the 
PPARγ agonist treated cells the iNOS expression after LPS stimulation 
was strongly reduced compared with non treated cells. 
From the EAE mice, a stronger AAM polarization of MRlysMcre mice than 





different to that observed in LPS stimulation. The above discussed data 
obtained from in vitro without source of massive GCs. In EAE model, the 
mice were treated several times with injections (1x Subcutaneous with 
Mog and CFA, 2x Pertusis) and suffered from the disease. These 
physiological stresses can promote the GC expression in the mice and 
elevate the GC concentration in serum, to which that the GRs in 
macrophage can be more activated than that under normal physiological 
conditions. Hence, in MRlysMcre macrohages due to lack of opposing effect 
by MR signaling, the activated GR can skew macrophages more 
preferentially to AAMs compared with in MRflox/flox macrohages. This may 
explain why the macrophages, both PMs and infiltrating cells from 
MRlysMcre EAE mice exert the similar AAM markers expression pattern 
compared with the GC induced AAM (Mantovani et al., 2002). 
From these data I conclude here that MR knockout can impact on 
macrophage polarization by exhibiting anti-inflammatory responses, 
particularly after pathogenic stimulation, but the cell characteristics are 
different from IL-4 or GC polarized AAMs. 
 
5.2 EAE development 
 
Despite extensive studies on MS patients and experimental research on 
animal models, the mechanisms underlying the physiopathology of MS 
remain only partially identified. However, the observation from 
relapsing-remitting MS suggests the presence of potent counter-regulatory 
mechanisms (Lassmann et al., 2007; Muzio et al., 2007). 
The growing evidence of macrophage functional heterogeneity in different 
pathologies raises questions of their role in inflammatory or 
anti-inflammatory reactions during MS. It has been demonstrated that the 





inflammatory cerebral ischemia (Frieler et al., 2011) and renal disease 
(Wang et al., 2007). Additionally, it has also been shown that the myeloid 
cell-specific MR knockout can potentially skew macrophage polarization 
towards AAM (Usher et al., 2010; Frieler et al., 2011). In light of these 
results, the effect of myeloid cell-specific MR knockout on EAE attracted 
our focus. 
In this project I performed the EAE in C57 BL/6 mice of two genotypes 
MRlysMcre and MRflox/flox. From three independent experiments I observed 
that MRlysMcre mice suffered significantly less from the EAE compared with 
MRflox/flox mice, especially, in the chronic phase. The histological images of 
lesion sites in spinal cord consistent with the observation of the severtity of 
EAE: in MRlysMcre mice, the myelin sheet was more intact than that in 
MRflox/flox mice. Because the MRlysMcre mice differ from the MRflox/flox mice 
only in the absence of MR in myeloid cells, particularly in macrophages, 
thereby suggesting that myeloid cell-specific MR knockout reduce the 
severity of EAE in genotype MRlysMcre C57 BL/6 mice significantly 
compared with that in genotype MRflox/flox.   
How does myeloid cell-specific MR knockout reduce the EAE severity in 
vivo? The possible explanation is provided by the comparison of gene 
expression in PMs and spinal cord infiltrating cells from both genotypes 
EAE mice. In both PMs and spinal cord infiltrating cells from MRlysMcre EAE 
mice, I detected an increase in expression of AAM markers genes, which 
are widely used to determine macrophage polarization (Mantovani et al., 
2004), compared with that in those cells from MRflox/flox EAE mice. 
Particularly, I observed an increase in the expression of Arginase1 and a 
reduction in the expression of iNOS. Arginase1 and iNOS are competitive 
for L-arginine, which is converted into L-ornithine and urea (Wu and Morris, 
1998) or citrulline and NO (Knowles and Moncada, 1994), by Arginase1 or 
iNOS, respectively. Thus, this opposing regulation of Arginase1 and iNOS 





EAE and MS (Farias et al., 2007; Aboul-Enein et al., 2006). Accompanying 
with the reduction in the severity of EAE, the macrophage functional 
heterogeneity was also altered by MR knockout. These gene expression 
evidences suggest that in MRlysMcre macrophages are more preferentially 
polarized to AAMs under EAE condition. However, I also observed that the 
other proinflammatory genes expression by spinal cord infiltrating cells 
was not altered by MRlysMcre. A possible explanation is that the spinal cord 
infiltrating cells include also other leukocytes, which participated in EAE 
pathology and also expressed those proinflammatory genes. On the other 
hand, our histological imaging of spinal cord infiltration showed that only 
macrophage infiltration was reduced in MRlysMcre EAE mice compared with 
MRflox/flox EAE mice, whereas the T lymphocyte infiltration was not 
distinguishable. Hence, the expression of those proinflammatory could be 
contaminated by the other infiltrating leukocytes, which is not the case of 
AAM markers, because these AAM genes are more unique in 
macrophages (Mantovani et al., 2004).  
Additionaly, the higher phagocytotic activity of the MRlysMcre macrophages 
is also a possible factor that reduces the severity of EAE in the chronic 
phase. Since EAE involves many leukocytes in its pathology, even the 
MRlysMcre macrophages are charaterised by anti-inflammatory profile, the 
myelin sheath and further axonal damage can still be caused by the other 
leukocyte, such as B cells and CD8+ T lymphocytes. Hence, a faster and 
more efficient regeneration of myelin and neuron is important by 
attenuating the disease severity. One essential factor for neuron 
regeneration is clearenc of debris around the lesion sites (Neumann et al., 
2009). As the in vitro data showed, both MR knockout PMs and BMDMs 
have higher phagocytotic activity by clearance the apoptotic cells. It is 
tempting to assume that these MRlysMcre macrophages are also more 
efficient by debris clearance than the MRflox/flox. However, here we can not 





myelin staining. We can not exclude the possibility that the less damaged 
myelin was a consequence of the anti-inflammatory response elicited by 
MRlysMcre macrophages. 
Previous data from our group showed that in treatment with 100mg Dex on 
three consecutive days the T lymphocytes are the major target of Dex 
treatment (Wüst et al., 2008), while the GR in macrophages is not 
essential for this treatment. This result was obtained from comparison 
within the two genotypes, GRflox/flox and GRlysMcre, with or without Dex 
application. In both genotypes, the severity of EAE was significantly 
attenuated after Dex application. However, the GRflox/flox mice were more 
accessible to Dex treatment than GRlysMcre mice. In the following paper 
published by our group (Schweingruber et al., 2011), the difference after 
treatment between both genotypes was observed again by using 
liposome-encapsulated Dex. The overall efficacy of therapy in GRlysMcre 
mice was reduced and accompanying with significantly higher NO 
production compared with GRflox/flox mice. After treatment, the 
macrophages exhibited significant AAM characteristic in gene expression 
pattern and less infiltrated in spinal cord, which are similar to the 
observations in this study. There are two conclusions I can draw from 
combining these previous data with my results. First, myeloid cell-specific 
MR knockout has similar effect on attenuating the severity of EAE 
compared with Dex application, especially through liposome. The two 
treatments are based on the same scenario: macrophages, in which the 
GR signaling is dominant to MR signaling, polarize preferentially towards 
AAMs. Because of the lack of 11βHSDII and much higher affinity of MR to 
GC than that of GR, MRs in macrophages bind constitutively with GCs 
even at lower GC concentration. Although the underlying mechanism is 
still unclear, from many studies that show MR inhibition or knockout can 
skew macrophage polarization towards AAM one can conjecture that MR 





activation requires a much higher local concentration to skew the 
polarization towards AAM (Mantovani et al., 2002). The application of Dex, 
especially via liposome, provides a local high concentration of Dex. In our 
case, disease caused stress can elevate the GC level in serum and 
additional with MR depletion, which help the GR signaling be dominant in 
macrophages. Hence, we observed the similar consequences after 
liposome-encapsulated Dex application compared with MR knockout. 
The MRlysMcre mice benefited from these AAMs anti-inflammatory and 
wound healing effect. Histological analysis showed in MRlysMcre mice the 
myelin sheath was significantly more intact than that in MRflox/flox mice in 
the chronic phase of EAE. However, we cannot determine whether in 
MRlysMcre mice the myelin sheath was less damaged by protection of 
anti-inflammatory AAMs or more efficiently regenerated.  
However, since the data show that MRlysMcre macrophages exert 
anti-inflammatory characteristics, which are beneficial for attenuating the 
severity of EAE, why there are not more, but less infiltrated macrophages 
in MRlysMcre to contribute to attenuate the inflammation in spinal cord? A 
possible explanation is: the EAE is an auto-immune disease, involves 
different leukocyte types, especially the Th1 and Th17 polarized T 
lymphocytes. Because macrophage polarization is reversible and tightly 
depends on the mircoenviroment, in which the macrophages locate, 
residing of macrophage around the activated T lymphocytes could be 
“dangerous” that the macrophage polarization strongly affected by 
cytokine from T lymphocytes, such as INFγ, which is well known to skew 
the macrophage polarization to CAM. This could be also the reason that 
the less AAM markers expression by infiltrating cells than that by PMs. 
 






I cloned a number of sequences of shGR, shMR and shSirt1 into the newly 
generated plasmid “FUTG-AgeI new”. The cloning procedure included 
three steps: 1) Preparation of oligos of shRNA, 2) Cloning of the oligos into 
the new plasmid, 3) Amplification of the constructs. By using the new 
plasmid the duration of shRNA cloning was reduced to 2 days, including 
sequencing. The following tests with the shGR sequence verified that this 
plasmid can efficiently knock-down target genes (Figure 17B). And the 
following functional tests identified that after Dox adiminstration the shGR 
transfected cells exert similar property compared with GR knockout cells 
(Figure 21A, B). These data imply that the newly generated plasmid is 
qualified for the inducible and reversible shRNA expression in host cells. 
According to my western blots I found that the most efficient sequence of 
shSirt1 was the “seq. 3” (Figure 19B). The protein band of Sirt1 from cells, 
which were transfected with the “seq.3”, vanished almost completely after 
Doxycycline treatment.  
In case of shMR, I found the most efficient sequence of shMR was the 
“seq.4” (Figure 18B). The protein band of MR from cells, which were 
transfected with the “seq.4”, vanished almost completely after Dox 
treatment. However, I cound not do functional test after induction of shMR 
expression like in case of shGR. Because we did not have a suitable 
mouse cell line for shMR knock-down test, I used the the HEK293 cells, in 
whicht mouse MR gene was exogenously transfected by pCDNA3 plasmid 
but does not have any physiological function in those cells. Nonetheless, I 
still generated lentiviruses with the “seq.4” of shMR and my colleague, 
Fischer, H., generated transgenic mice with the lentiviruses. 
After transferring the viral infected embryos into the oviduct of 
peseudopregnant female mice, we got 8 offsprings. The flow cytometry 
data of tail blood of these offsprings (Figure 22A) revealed in the three 
offsprings, No. 2, No. 5 and No. 8, the shMR construct was expressed by 





with successful integration of the lentiviral construct. These data indicate 
that the new transgenic mice were successfully generated. After breeding, 
further physiological experiments about MR will be performed. 
I generated the lentiviral vector “FUTG-AgeI new” that differs from 
“FH1tUTG”, used in Herold et al., 2008, in 1) that all the components are 
placed in the vector and shRNA cloning sites are modified and 2) the 
mutation of the last 6 bp of H1 promoter only guarantees the reading frame 
by expressing shRNA without any affect on promoter activity (Myslinski et 
al., 2001). Therefor, the lentiviral vector system “FUTG-AgeI new” inherites 
all the advanced features from the lentiviral vector system “FH1tUTG”: 1) 
all components necessary for inducible shRNA expression are placed in 
one single vector, which reduces the need to cross-breed several strains of 
animals; 2) EGFP expression simplified the identification of transgenic 
offspring, transcriptionally active proviral integrations and controlling for 
possible mosaicism; 3) Gene knockdown is strictly triggered by 
administration of Dox, which prevents a lethal knockdown phenotype 
caused by continuous gene knockout; 4) in vitro, inducibility of the most 
efficient sequence is very rapid, leading to an almost complete loss of the 
targeted protein; 5) the sensitivity of the system is high and allows protein 
knockdown at low Dox concentration, thereby reducing the risk of side 
effects. Though there was no in vivo test performed, according to relative 
research reported by Herold et al., 2008, and the highly similar construct in 
the lentiviral vector, similar in vivo characteristics in knockdown is 
reasonable highly possible. 
Nonetheless, the “FUTG-AgeI new” system still has some drawbacks. First, 
differing from the homologous recombination that the recombinase can be 
driven by differen cell type specific promoter, like here used LysM promoter, 
the shRNA expression can only be driven by promoter using RNA 
polymerase III (Tuschl, 2002; Brummelkamp et al., 2002), in case of this 





is not possible by using the lentiviral system alone and cell transplantation 
is possibly required. Second, the kinetic of doxycycline is different in 
organs, for example: as consequence of the lower local Dox concentration 
in brain (Seibler et al., 2007) a 100 fold administration of doxycycline 
compared with that in other tissues should be considered, in order to 
achieve strong protein knockdown, which may leads to a side effect; in 
muscle the restore of target gene after stopping Dox treatment delays 
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